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ABSTRACT

Cardiovascular disease is the leading cause o f death in North America. Cardiac
infarction caused by thrombus plaque rupture can often lead to sudden death. Arterial
stenosis caused by atherosclerosis is an important precursor leading to thrombus
formation. Shear stress, abnormal lipid metabolism, and subendothelial layer exposure
are the major contributors to arterial thrombus formation. Platelet activation by the above
factors, followed by adhesion is the basic sequence in thrombus formation.
Platelets were encapsulated with nanofilm in order to reduce platelet activation
and adhesion under high shear stress. Polyions, nanoparticles and immunoglobulins were
assembled in nano-organized shells on fixed bovine platelets through the electrostatic
layer-by-layer (LbL) self-assembly technique. The coverage o f 78-nm silica and 45-nm
fluorescent nanospheres on
microscopes.

An

platelets was studied

IgG-layer

poly(styrenesulfonate),

and

was
its

adsorbed

specific

on

under TEM or fluorescence
platelets

immune-recognition

in
and

alternation

with

targeting

with

fluorescent anti-IgG-FITC were demonstrated. Not only limited to fixed platelets, live
platelets were also coated with polyions with a outermost layer o f heparin. Most platelets
were alive and not activated after the coating procedure and no obvious cytotoxicity was
observed.
A coronary artery stenosis silicone model was built to test encapsulated platelet
function under high shear stress generated by the stenosis. In the platelet activation study,

iii
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encapsulated platelets released less TXB 2 compared with unmodified platelets. Platelets
with heparin coating were not that easily adhered onto collage substrate in silicone model
after the flow experiment. The heparin shell might block the possible binding reactions
between collagen and platelet surface glycoproteins.
In conclusion, the nano-engineered platelets expressed less activation and
adhesion under high shear stress.
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CHAPTER 1

INTRODUCTION

1.1 Introduction
Platelets possess unique features that facilitate their functions in the hemostasis.
Among these are the ability to secrete multiple substances, such as adenosine diphosphate
(ADP), serotonin, and thromboxane A 2 (TXA 2 ) that recruit other platelets to a forming
thrombus through a dramatic positive feedback mechanism.

Platelets are also able to

express membrane receptors for thrombin, von Willebrand factor (vWF), fibrinogen, and
other proteins that support adhesion and aggregation in a way that enhanced by
hemodynamic shear stress (Baumgartner et al., 1980). They also support a mechanism
for uptake o f serotonin (Glynn, 1973). Platelet thrombus contributes to the development
o f atherosclerosis (Duguid et al., 1985), directly causes myocardial infarction (Fuster et
al., 1985; Fuster et al., 1990; Mustard et al., 1990). Because o f the unique features o f
platelets and the importance o f platelets to cardiovascular health and pathology, it is of
interest to examine the possibility o f modifying these cells, either as a therapy for
diseases caused or exacerbated by platelets, or as a means to provide them with new
functions, such as drug delivery or biochemical sensing.

1
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A type o f platelet modification is already being used as a therapy for patients who
have coronary artery disease.

It involves the use o f an antibody to the membrane

receptor, GPIIb-IIIa, that is responsible for adhesion o f platelets in a high shear stress
environment, such as that found in an arterial stenosis (Hanson et al., 1988).

This

method works through the injection o f a monoclonal antibody (e.g., abciximab) to the
receptor into the body. An alternative is to extract platelets, modify them in vitro, and
then return them to the circulation.

If such a method is to be useful, it must take

advantage of the unique properties o f platelets, such as their ability to actively secrete
agents upon activation. An example is the use o f platelets as a drug delivery device. The
advantage o f platelet is that the platelet, when activated, actively secretes the drug at the
targeted location, rather than slowly and passively releasing the drug.
Recently a method has been developed by Iler (1966) in which a thin (nanoscale)
film can be adsorbed onto a surface through the sequential exposure o f the surface to
solutions of alternately charged colloidal particles and proteins. The technique is
particularly useful because o f its applicability to any charged surface and its ability to
radically change surface properties without substantially increasing the size o f the object
being modified.

For example, the release rate o f a dye (Antipov, 2001) or drug

microcrystals (Qiu, 2001; Ai, 2002b) can be controlled through nano-encapsulation, and
because the coating is thin, the size o f the resulting microcapsule is small enough to be
injected.
Platelets have been successfully encapsulated with polyions, antibodies, and
nanoparticles (Ai, 2002a). The shell formed on platelets may block agonists from
reaching platelet receptors, thus reducing platelet activation or adhesion. Similarly, the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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secretion o f agonists from platelets can be controlled by the shell. Localized targeting o f
platelets can be achieved if the surface is coated with anti-IgG.
In an effort for researcher to understand how nano-engineered platelets react to
high shear stress caused by an arterial stenosis, platelets have been encapsulated by the
layer-by-layer technique and their behavior was examined in an in vitro silicone coronary
artery stenosis model. Platelet activation and adhesion, and the NO release from
endothelial cells were examined. Blood Thromboxane B 2 (TXB 2 ) was measured by
enzyme-linked immunosorbent assay (ELISA) as a measure of overall platelet activation.
Platelet adhesion to a collagen substrate on the inner surface o f the silicone model was
quantified through fluorescence tagging. The amount o f NO release from endothelial
cells was measured with a cell membrane permeable fluorescence sensor. The overall
purpose o f this study was to determine whether nano-encapsulated platelets express less
activation and adhesion than unencapsulated platelets under the high shear stress
generated by the stenosis.

1.2 Background and Significance
1.2.1 Coronary Artery Stenosis
Cardiovascular disease is the leading cause o f death in North America (Malek et
al., 1999). Cardiac infarction induced by thrombus plaques can often cause sudden death
(Fuster et al., 1985; Fuster et al., 1990; Mustard et al., 1990), and arterial stenosis caused
by atherosclerosis is an important step leading to thrombus formation (Malek et al.,
1999). The National Health and Nutrition Examination Survey III (NHANES III) reports
that 60,800,000 Americans have one or more types of cardiovascular disease (CVD).
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Among these patients, about 20.4% have coronary heart disease, 12% have myocardial
infarction, and 10.5% have angina pectoris. The hemodynamic environment and
biochemical factors affected by the existing stenosis are o f great importance in further
formation o f thrombus (Goto et al., 1998; Badimon et al., 1986; Malek et al., 1999;
Weigensberg et al., 1975; Murata et al., 1969; Honour et al., 1978; Sekimoto, 1980;
Naqvi et al., 1999). Hemodynamic wall shear stress is important for platelet activation,
subsequent adhesion and aggregation (Malek et al., 1999). While arterial stenosis caused
by atherosclerosis is an important precursor to thrombus formation, no direct relationship
has been shown between stenosis severity and acute coronary thrombosis or restenosis
from past studies (Ambrose, 1988; Ellis, 1989a); some patients who had myocardial
infarction might not have serious stenosis (Ambrose, 1988; Little, 1996). Therefore, it is
important to understand the relationship between stenosis and thrombus formation if the
mechanics for myocardial infarction is to be fully understood. The pathogenesis of
thrombosis consists o f two processes: atherosclerosis and thrombosis (Prentice, 1990).
The mechanism for thrombus formation is complicated, and many mechanical and
biochemical factors are involved. Shear stress (Goto, 1998; Badimon, 1986; Malek,
1999), abnormal lipid metabolism (Weigensberg, 1975; Murata, 1969; Honour, 1978;
Sekimoto, 1980; Naqvi, 1999), and subendothelial layer exposure (Weiss, 1986;
Badimon, 1986; Badimon, 1988) are the major contributors to arterial thrombus
formation. Platelet activation by the above factors, followed by adhesion, is the basic
sequence in thrombus formation. Under pathologic conditions, ruptured plaques and high
shear stress at sites o f stenosis may induce formation o f platelet-rich thrombi that become
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life-threatening when they occlude the vascular lumen and block blood flow (Fuster,
1992a; Fuster, 1992b).
Many previous studies have shown platelet adhesion on damaged endothelial
cells (Dewitz et al., 1978; Moritz et al., 1988; Belval et al., 1984; Ikeda et al., 1991;
Huang et al., 1993), but thrombus formation has rarely been observed on an intact
endothelium (Rosenblum, 1997). Nitric oxide (NO), an important intracellular and
intercellular messenger released from endothelial cells, can prevent platelet activation
and adhesion (Mellion et al., 1981; Salvemini et al., 1989). Less release o f NO at
downstream locations from stenosis may increase the adhesion o f activated platelets.
Coronary angioplasty, thrombolysis, or a combination o f these therapies, are
commonly used in the treatment o f coronary stenosis. Coronary Artery Bypass Graft
(CABG) Surgery is also a popular method to relieve symptoms (Arcidi, 1988). Coronary
angioplasty is an effective and popular treatment for acute myocardial infarction (Ellis,
1989b; Steg, 1999; Grines, 1999; Lane, 2000; Bar, 2000) and coronary stenosis
(Borrione, 1993; Conti, 1991; Liska, 1999; Shin, 1999). Restenosis after the angioplasty
procedure (Buchwald, 1990; Klein, 1990; Schwartz, 1990; Marzocchi, 1991), and
bleeding side effects caused by thrombolysis are not uncommon (Cohen, 1998; de Bono,
1993; Erlemeier, 1989). Polymorphism o f platelet glycoproteins (Abbate, 1998; Bottiger,
1999; Kastrati, 1999), higher platelet aggregation (Goel, 1997), and platelet-vessel wall
interaction (Hoylaerts, 1997) are all involved in restenosis. CABG failure was also
reported due to different factors (Pitrowski, 1991; Yang, 1997; Rasmussen, 1997).
Endothelial nitric oxide synthase (eNOS) gene delivery has been used as a method for the
treatment endothelial cell dysfunction (Lake, 1999; Sato, 2000). Blood vessel relaxation
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(Lake, 1999) and smooth muscle cell growth inhibition (Sato, 2000) were achieved
through gene transfer to endothelial cells. This is a promising approach but requires
substantial work before it can be applied clinically.

1.2.2 The Role of Platelet Glycoproteins in Platelet
Activation. Aggregation and Adhesion
Platelets have several effects in the cardiovascular system, including blood vessel
reparation,

clot

formation,

clot

retraction,

clot

dissolution,

vasodilation,

and

vasoconstriction. When activated, platelets change from the normal disc shape to a
compact sphere with long dendritic extensions facilitating adhesion (Figure 1.1). Also,
the activated platelet surface membrane area increases about 60% after activation (Bom,
1970). This fact increases the probabilities that the platelet will attach to the
subendothelial matrix or adhere to other platelets. Fibronectin, collagen fibers,
vitronectin, and VWF in the subendothelial matrix are the targets for those surface
glycoproteins to bind.

S ' -

Figure 1.1 SEM of activated platelets (George, 2000)
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Platelet adhesion to endothelial cells can be induced by thrombin (Venturini,
1992), collagen (Ross, 1995b), shear stress (Huang, 1993), and many other factors. When
activated, platelets will adhere to a damaged endothelial cell layer (Badimon, 1986;
Hoylaerts, 1997). But platelet adhesion and aggregation without endothelial denudation
or exposure o f basal lamina and/or collagen has also been reported (Rosenblum, 1996).
Platelets are disk-shaped cells with diameters from 2 to 4 microns and volumes
from 5 to 7.5 pm 3 and derived from megakaryocte cytoplasm fragments. Generally, two
types o f granules are in platelet cytoplasm, a lysosomal granules and dense granules.
Partial release o f acid hydrolases from lysosome-like organelles has also been reported
(Holmsen, 1992). The a granules secrete adhesive proteins such as von Willebrand factor
(VWF), platelet-derived growth factor (PDGF), platelet factor 4 (PF-4), fibronectin,
thrombospondin and fibrinogen, and plasma proteins such as albumin and IgG (Sander,
1983; Stenberg, 1984; Kaplan, 1979a; Kaplan, 1979b). While very dense granules secrete
serotonin (White, 1968), ADP, and Calcium (blood coagulation factor IV) (George,
2000). The membranes o f platelets, mainly composed o f lipids and glycoproteins, are of
special interests in the platelet activity study. This cell coat, about 150 to 200 nm thick
(Zucker-Franklin, 1990), prevents platelet adhesion to a normal endothelial layer and
helps platelets attach to a damaged cell layer (Guyton, 1996; Faull, 1994). There are at
least 30 distinguishable glycoproteins on the platelet surface (Holmsen, 1990). Some
glycoproteins, together with platelet endothelial cell adhesion molecule 1 (PECAM-1)
and P-selectin, are important adhesion receptors on platelets (Table. 1.1).
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Table 1.1 Adhesion Receptors on Platelets*
Receptor

Ligand

Number/cell

cciibp3(GPIIb-IIIa)
a vp3(GPV-IIIa)
a 2p, (GPII-IbP)
a 5p, (GPV-Ibp)
a 6p, (GPVI-Ibp)

Fibrinogen, vWF, Vn, Fn
Fibrinogen, vWF, Vn, Fn, OP
Collagen
Fn
Laminin

80,000
250
<1,000
<1,000
<1,000

Leucine-rich motif

GP Ib-IX

VWF

25,000

Immunoglobulin

PECAM-1

PECAM-1, GAGs

5,000

Gene family
Integrin

Selectin
P-selectin
CHO on WBC
10,000
*: Modified from Shattil et al., 1994.
Vn: vitronectin; Fn: fibronectin; OP: osteopontin; GAGs: glycosaminoglycans;
PECAM-1: platelet endothelial cell adhesion molecule; CHO: sialylated and fiicosylated carbohydrates
displayed on specific membrane proteins

GPIIb-IIIa is the most important glycoprotein in platelet aggregation and adhesion
(Jennings, 1986; Pytela, 1986; Plow, 1984). GPIIb-IIIa is an integrin that consists o f a
two-chain a unit bound noncovalently to a single-chain p unit (Shattil, 1998). It is the
most abundant surface glycoprotein (Holmsen, 1990), with 80,000 receptors on the
platelet surface (Wagner, 1996), and it requires a conformational change during platelet
activation to express receptor function, mainly for fibrinogen (Shattil, 1985; Shattil,
1997; Shattil, 1998). GPIIb-IIIa also attaches to vWF (Ruggeri, 1982), fibronectin
(Ginsberg, 1983), and vitronectin (Fitzgerald, 1987; Fijnheer, 1990). Activated platelets
express about 45,000 to 50,000 GPIIb-IIIa receptors on the surface, which is 56.2% to
62.5% o f the total resting receptors (Shattil, 1985; Abrams, 1991). Peptides containing
the amino acid sequence Arg-Gly-Asp (RGD), a sequence present at two locations in the
a chain o f fibrinogen, can be recognized by GPIIb-IIIa in the binding process (Bennett,
1988). This binding is activation-independent (Lam, 1987; Frelinger, 1988). Accurate
information on the amount o f expressed GPIIb-IIIa aids in the analysis o f platelet
activation. Several methods have been applied in past studies, but flow cytometry is
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widely used and has proved to be effective (Abrams,

1990; Andrews, 1996;

Konstantopoulos, 1995; Lindahl, 1992; Michelson, 2000; Warkentin, 1990; Yano, 1994).
To better explain the working principle o f GPIIb-IIIa in platelet activation,
integrin signaling was proposed (Shattil, 1998). Integrin signaling includes inside-out
signaling and outside-in signaling. Inside-out signaling denotes those reactions initiated
by the binding o f one or more agonists to their plasma membrane receptors, leading to the
conversion o f GPIIb-IIIa from a low-affinity/avidity receptor to a high-affinity/avidity
receptor (Shattil, 1998). Outside-in signaling triggers a number o f postligand binding
events and these require cooperative signaling between GPIIb-IIIa and agonist receptors.
The integrin signaling is illustrated in Figure 1.2. Affinity modulation is depicted
hypothetically as a signal-induced rotation o f the Ilia subunit to generate and unmask
fibrinogen binding sites in the extracellular domains o f GPIIb-IIIa (Shattil, 1998).

Fibrinogen
Agonists

«llb P3

S ignaling
R eactio n s

1. inside-out
2. Outside-in

ow ®

S ignaling
R eaction s

C ytoskeletal
C hanges

------------_
“

Post-ligand
binding events

la: inside-out signaling increases the affinity o f GPIIb-IIIa
lb: inside-out signaling increases the avidity o f GPIIb-IIIa

Figure 1.2 Integrin signaling (from Shattil, 1998)
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Other glycoproteins are also o f great importance in platelet activation,
aggregation and adhesion. GPIX, a 17-kDa to 22-kDa single-chain platelet membrane
glycoprotein, can noncovalently bind with GPIb and GPV to form GPIb-IX-V complex
(Du, 1987; Modderman, 1992). This glycoprotein plays important functions in normal
platelet activation and adhesion (Hourdille, 1990; Ruggeri, 1991). The GPIb-IX-V
complex contains a VWF binding site that mediates the activation-independent, sheardependent adhesion o f platelets to the exposed vascular subendothelial layer (Du et al.,
1987; Fox et al., 1988; Hickey et al., 1989; Ruggeri et al., 1991; Modderman et al., 1992;
Michelson et al., 1991). PECAM-1, a 130-kDa to 140-kDa single-chain integral
membrane protein, functions as a vascular cell adhesion molecule, also involved in
thrombosis (Albelda et al., 1991; Horak et al., 1992). P-selectin, also known as platelet
activation-dependent granule-external membrane (PADGEM) protein (Hsu-Lin et al.,
1984) or granule membrane protein (GMP-140) (Stenberg et al., 1985), is a 140-kdalton
single-chain polypeptide (McEver, 1990).
Fibrinogen (blood coagulation factor I), a 340-kDa glycoprotein (Caspary et al.,
1957), is present in platelet a granules. While endothelial cells do not synthesize
fibrinogen, and fibrinogen is not normally present in the subendothelial layer, fibrinogen
is present in the subendothelium of healing blood vessels (Clark et al., 1984; Fujikawa et
al., 1984). This glycoprotein is considered an interplatelet linkage after platelet activation
and the conformational change o f GPIIb-IIIa (Hawiger, 1991).
The large multimeric glycoprotein vWF contains a variable number of subunits.
It is contained in platelet a granules and synthesized and secreted by endothelial cells
(Jaffe, 1974; Wagner, 1984; McCarroll, 1985). The concentration o f VWF in the plasma
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is about 7-10 {ig/ml (Girma, 1986). VWF functions as a molecular anchor between the
subendothelium and platelets (Hawiger, 1991). It binds to the subendothelium, changes in
conformation, and is then able to interact with GPIb (Sixma, 1991). VWF deposited in
the subendothelium is responsible for up to 40% o f normal adhesion, and the action of
VWF is seen at high shear rates (Sixma, 1991). VWF binds at the cell surface interface
between platelets (Senogles, 1983), which can promote further platelet aggregation.
Collagen fibers are one o f three principal connective tissue fibers widely
distributed in the body. Nineteen different types (Kehrel, 1995) o f collagen have been
identified, and each collagen molecule is composed o f three polypeptide a chains in a
helical configuration (Ross, 1995a). At least nine o f the different collagens - type I, III,
IV, V, VI, VIII, XII, XIII, XIV are found in the vessel wall (Kehrel, 1995). Collagen is
exposed when the endothelium is damaged. The interaction o f platelets with collagen is
complex because the collagen monomer has no affinity to platelets, while collagen fibrils
and immobilized collagen bind strongly to platelets (Moroi, 1997). Many studies have
shown that platelets can attach to collagen in a flow condition (van Zanten, 1996; Huang,
1998; Mazzucato, 1999; Moroi, 1996; Ross, 1995b; Saelman, 1995).
Collagen types I, III, V and VI can induce a-granule secretion and up-regulation
o f cell surface GPIIb-IIIa (Alberio, 1998). Platelet adhesion and aggregation on collagen
VI are different in shear rate dependence from collagen I; collagen VI and vWF may play
a role under low shear rates (Ross, 1995b). Chiang et al. (1993) suggested that type I and
type III collagens interact with platelets at separate sites. Platelet adhesion to collagen
type III is strongly but not completely determined by the adhesive properties o f vWF
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(Wu, 1996). Collagen type IV is a sheet-forming collagen and a major constituent o f the
vessel wall. It is a reactive collagen for platelets (Henrita, 1996).
Platelet glycoproteins are the major receptors for collagen attachment. Collagenplatelet interaction, occurring in hemostasis and thrombosis, is a two-step process o f
adhesion and activation involving the sequential recognition of distinct receptors (Barnes,
1998). The normal platelet adhesion to collagen is mediated through the binding to vWF
to collagen and to both GPIb and GPIIb-IIIa on the platelet membrane (Fressinaud,
1988). Adhesion involves first the reversible recognition o f collagen-bound VWF by the
platelet receptor complex a llp l, which binds to a specific sequences in collagen in which
the GER m otif appears important (Bames, 1998). It was suggested that both the a lip i
integrin and GPVI are involved in inside-out signaling leading to activation o f GPIIb-IIIa
complex after platelet adhesion to collagen and generation of TXA2 may further enhance
expression o f activated GPIIb-IIIa (Nakamura, 1999).
GPIV (CD36) does not play a major role in collagen-dependent platelet signal
transduction (Daniel, 1994). Integrin GPIa-IIa is a major platelet receptor for collagen
(Estavillo, 1999). But it is shown that the a(2)-I domain can prevent platelet adhesion to
a collagen surface exposed to flowing blood under low shear stress (Estavillo, 1999).
Other factors are also related to collagen-platelet interactions. It was suggested
that platelet-activating factor (PAF) plays an important role in collagen-induced whole
blood aggregation (Oura, 1994). Collagen fibers could inhibit platelet membrane
adenylate cyclase in a dose-dependent manner (Famdale, 1992).
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1.2.3 Thromboxane B?: An Indicator of Platelet Activation
Thromboxanes also play important roles in platelet activation and aggregation.
The pathway o f thromboxane B2 is illustrated as in the Figure 1.3. During platelet
activation arachidonic acid is liberated from certain glycerophospholipids (Holmsen,
1990b). PGG 2 and PGH 2 are subsequently converted from arachidonic acid. PGG 2 and
PGH2 are unstable in an aqueous environment (half-life time: Ti/2 = 300 s) and may be
converted nonenzymatically to the stable prostaglandins (Smith, 1987a). Thromboxane
A2 is derived from PGH 2 by thromboxane synthase. The half-life time o f TXA 2 is about
32 seconds (Samuelsson, 1976). TXA 2 , a potent platelet agonist and vasoconstrictor
(Smith, 1987b), can promote further platelet aggregation. Thromboxane B2 , converted
from thromboxane A 2, is an indicator o f TXA 2 production with a half-life time 20 ~ 30
minutes (McCann, 1981; Fitzpatrick, 1977). Intact endoperoxides, PGE 2 , and PGF 2a
account for only a very small part o f the transformation via the cyclooxygenase pathway,
the main products being Ci 7-hydroxy acid (HHT) and TXB 2 (Samuelsson, 1976). It was
found that aggregation o f washed platelets by thrombin was accompanied by release o f
large amounts o f end products such as TXB 2 from arachidonic acid metabolism
(Hamberg, 1974). So TXB 2 concentration indicates the degree o f platelet activation and
aggregation. The level o f TXB 2 is about 2.45 pg/ml after thrombin-induced aggregation
o f human platelets (Samuelsson, 1976). It can be easily measured through a TXB 2
enzymeimmunoassay (ELA) system (Biotrak, 1994) with a sensitivity o f 3.6 pg/ml.
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Figure 1.3 The pathway o f thromboxane B?

1.2.4 Shear Stress Plavs Important Roles in Platelet
Activation and Adhesion
The mechanism involved in platelet activation, aggregation, and adhesion is
complicated, and shear stress is an important mechanical factor in many aspects.
Morphological, biochemical, and functional changes of human platelets were found at
high shear stress (Brown, 1975). Shear stresses of 50 dynes/cm2 and higher trigger
platelet activation, cause the4 release of granule contents into the suspending medium,
and elicit platelet aggregation (Dewitz, 1978; Moritz, 1988; Belval, 1984; Ikeda, 1991;
Huang, 1993).
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The magnitude o f shear stress in a cylindrical tube is proportional to blood flow
viscosity, and inversely proportional to the third power of the blood internal radius. The
relationship is expressed by the solution for Poiseuille flow:

4m Q
k

R3 ’

where r is shear stress, fj. is dynamic viscosity, Q is flow rate, and R is the radius o f
the vessel. This equation assumes fully developed flow and ignores effects found in the
arterial system such as curvature, branching and tapering.
Measurements using different modalities show that shear stress ranges from 1 to 6
dynes/cm2 in the venous system and between 10 and 70 dynes/cm2 in the arterial vascular
vessels (Malek, 1999). The range o f wall shear stress magnitude is shown in Figure 1.4.

Normal vein
Normal Artery
Atherosclerosis
prone arterial regions
High-shear thrombosis
(complex plaque,
cardiac valves, stents)

-4

4

6

10
70
Shear Stress, dyne/cmA2

100

Figure 1.4 Range of wall shear stress magnitude (modified from Maiek, 1999)
The biochemical environment can be changed due to abnormal fluid mechanical
conditions. In areas o f vessel stenosis, in arterioles, or in the microcirculation, the effects
o f vWF are more important at high shear rates (Baumgartner, 1980; Turitto, 1983;

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

16

Turitto, 1985). It was suggested that shear stress-induced binding o f vWF multimers to
platelet GPIb, causes an increase o f [Ca2+] and platelet aggregation, both o f them
potentiated by vWF binding to the platelet GPIIb-IIIa complex (Chow, 1992). The
reactivity o f the exposed materials and the local shear rate, defined by the blood flow and
the luminal cross section, can regulate platelet deposition to injured vascular wall
(Badimon, 1986).
Shear stress can bring platelets close to the wall through convection and enhanced
diffusion (Aarts, 1988). With the laser-Doppler technique, Aarts et al. (1988) found red
blood cells were in the center o f blood flow, while platelets were concentrated near the
wall. This high concentration at the wall increased with higher average tube hematocrit
and wall shear rates. The authors suggested that platelet transport might be enhanced by a
shear rate-dependent rotary motion. In a stenosis model, deposition onto the wall
depended on the wall shear stress distribution along the stenosis, increasing in areas of
flow recirculation and reattachment (Bluestein, 1997).

1.2.5 Nitric Oxide Released from Endothelial Cells
Nitric oxide (NO), a free radical, is an important messenger in the biological
system. NO has crucial roles in vasodilation (Palmer, 1987), inhibition o f platelet
aggregation (Mellion, 1981; Salvemini, 1989), intercellular communication in the central
nervous system (CNS) (Garthwaite, 1988), neurotransmission in peripheral nervous
system (PNS), atherosclerosis formation (Bruckdorfer, 1990), osteoclastic inhibition
(MacIntyre et al., 1991), and many other physiological functions (Lowenstein, 1994).
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NO could be produced by all kinds o f cells (Moncada, 1991). NO is produced
from L-Arginine by nitric oxide synthase (NOS) in the physiological system (Murad,
1999). Three isoforms of mammalian NOS have been identified in the past studies.
Neuronal NOS (nNOS or NOS-1) was first characterized from rat cerebellum (Bredt,
1990). Inducible NOS (iNOS or NOS-2) was purified from mice macrophages (Stuehr,
1991) and endothelial NOS (eNOS or NOS-3) was found in bovine aortic endothelial
cells (Forstermann, 1991).
It was found that humans and other mammals maintain a finite steady state
concentration o f nitric oxide in the circulation (Freeman, 1978). But a decrease in the
bioavailability o f NO is a characteristic feature in those patients with coronary artery
disease (Zeiher, 1996).
NO can inhibit platelet aggregation via activation o f intraplatelet soluble
guanylate cyclase, increases cyclic GMP (cGMP) (Mellion, 1981, Lieberman, 1991).
Fibrinogen binding to platelets is also inhibited by NO (Mendelsohn, 1990). Platelets can
adhere to a damaged endothelial layer, collagen, and other surfaces, while NO can reduce
(Sneddon, 1988) and inhibit (Radomski, 1987) platelet adhesion to vascular endothelial
cells. Substances released from a granules and dense granule secretion (Broekman, 1991;
Lieberman, 1991) can be inhibited. Michelson et al. (1996) reported that 1) the increased
cGMP level by NO can negatively regulate the platelet surface expression o f P-selectin,
CD63, and the Gllb/IIIa complex but not the platelet surface expression o f GPIb-IX
complex and 2) hemoglobin within erythrocytes inhibit the effects of NO on platelet
surface glycoproteins.
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1.3 The Laver-bv-Laver Self-Assembly Technique
1.3.1 Introduction
Her (Iler, 1966) was the pioneer who developed the principle o f alternate
adsorption for film formation o f charged colloidal particles and proteins. Later, layer-bylayer (LbL) self-assembly by means o f alternate adsorption o f linear polycations and
polyanions was introduced (Decher, 1991, 1997, 1993, 1994a; Lvov, 1993d; Lvov,
1993a; Lvov, 1993c; Lvov, 1993b). The assembly procedure is presented in Figure 5. A
positively charged surface is first coated with polyanions followed by polycations. The
outermost layer is negatively charged nanoparticles. The assembly steps can be repeated
for further deposition o f polyelectrolytes or nanoparticles. Naturally, polyions have to be
used at pH levels that provide a high degree o f ionization.
It is important to have the resaturation o f polyion adsorption, resulting in the
alternation o f the terminal charge after every subsequent layer deposition, which implies
that there is no principle restriction to the choice o f polyelectrolytes. There is the
possibility o f designing ultrathin ordered films in the range o f 5 to 1000 nm, with a
precision better than 1 nm and a definite knowledge o f their molecular composition. This
technique has been applied successfully to many water-soluble polyions (including
conductive polyions, polysaccharides, polypeptides, DNA and polynucleotides) (Lvov,
1994a, 1994b; Mao, 1993; Decher, 1994b; Hong, 1993; Schmitt, 1993; Korneev, 1995,
Leasche, 1998; Cheung, 1994; Yoo, 1998), dyes (Yoo, 1996; Ariga, 1997) and proteins
(Lvov, 1994c &, 2000; Brynda, 2000). Additionally, viruses (Lvov, 1994a), ceramics
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(Kleinfeld, 1994), and charged nanoparticles (Kotov, 1995; Schmitt, 1997; Lvov, 1997;
Lvov, 1998a) have been used in LbL assembly.
Protein / polyion multilayer assembly allows proteins to be organized in layers
and to build up such layers following "molecular architecture" plans (Lvov, 2000). The
method has been extended to build up multiprotein films, i.e. alternate monolayers o f
proteins in predetermined orders. It is important to use alternating linear or branched
polyion layers for the successful assembly o f protein multilayers. Flexible linear polyions
penetrate between protein globules and act as electrostatic glue. The concept of
“electrostatic polyion glue,” which keeps together neighboring arrays o f proteins, is
central to this approach.
A standard approach for film preparation is as following: (1) An aqueous solution
o f polyion and protein at concentration o f 0.1 - 1 mg/mL is adjusted in pH such that the
two components are oppositely charged. For proteins, we shifted the solution pH on 1-2
units from their isoelectric point to provide 20-60 elemental charge units for a globule.
(2) A substrate is selected that carries a surface charge (e.g., plates or polymer filters
covered by a layer o f cationic poly (ethylenimine) (PEI) which may be readily attached to
many surfaces). (3) The substrate is alternately immersed in polyion and protein solutions
for 20 min with 1 min intermediate water rinsing. The pH o f the rinse solution is selected
to keep the polyions ionized. (4) The sample is usually dried in a stream o f nitrogen,
although drying may disturb the assembly process, and is not necessary for the procedure.
The polyion predominately used in the assembly: polycations - poly(ethylenimine) (PEI),
poly(dimethyldiallylammonium chloride) (PDDA), poly(allylamine) (PAH), poly(lysine),
chitosan; polyanions - poly(styrenesulfonate) (PSS),

poly(vinylsulfate), poly(acrylic
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acid), heparin, dextran sulfate, sodium

alginate, and

DNA.

Polypeptides and

polysaccharides are essential in forming biocompatible nanofilms.
X-ray reflectivity measurements o f polyion films adsorbed from aqueous
solutions show patterns with profound intensity oscillations. From the periodicity o f these
oscillations (Kiessig fringes), the thickness o f a single polyion layer can be calculated as
the total film thickness (Decher, 1997; Lvov, 1993d) and knowing the number o f the
adsorption steps. Growth steps o f 1.1 - 2.0 nm per bilayer are typical for linear polyanion
/polycation assemblies, while the thickness o f each monolayer often equals one half of
this value (Lvov, 1993d; Lvov, 1993a; Lvov, 1993c; Lvov, 1993b; Decher, 1993; Decher,
1994a; Lvov, 1994a; Lvov, 1994b). These values correspond to a polyion cross-section
and show that in one cycle o f excessive adsorption approximately one monolayer covers
the substrate. Polyion films are insoluble in water and in many organic solvents and are
stable to at least 200°C (Lvov, 1993a; Lvov, 1994b).
The outermost layer o f a film dominates the film surface property (Yoo, 1996).
The contact angle o f a coated film was different from the substrate after surface
modification (Yoo, 1998; Ai, 2002c; Ai, 2002d; Ai, 2002e). A hydrophobic surface can
be changed to hydrophilic by applying different films on it. PEI, PSS, Gelatin, Poly-Dlysine, and collagen nanofilms decrease the contact angle on silicone rubber. These
materials were used to assemble ultrathin films on silicone for cell adhesion and growth.
The thickness o f each individual layer and the total film thickness can be adjusted
precisely by changing the ionic strength o f the solution from which the polyions are
adsorbed (11). Neutron reflectivity analysis o f the films composed o f alternate layers o f
poly(styrenesulfonate) (PSS) and hydrogen containing polyallylamine (PAH) has proved
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that polyanion / polycation films possess a uniform thickness and a multilayer structure.
The interfaces between layers in polyion films are not sharp but exhibit partial
interpenetration (30 % o f their thickness) between neighboring polymeric layers (Decher,
1997; Schmitt, 1993; Korneev, 1995; Leasche, 1998). A distinct spatial component
separation may be achieved between the first and the third or fourth neighboring polyion
layers (Decher, 1997).
LbL assembly is a fundamental approach for designing organized films that
contain different protein monolayers in precise locations. The production o f ordered
protein / polyion multilayers is an easy and general process, which may be applied to any
water-soluble protein providing a surface charge. The technique lends itself to several
biomedical applications. First, biosensors can be fabricated by using different proteins
with a predetermined order that would produce sequential enzymatic reactions. Second,
bio/nanoreactors can be made by deposition o f enzyme/polyion multilayers onto nanocarriers. Third, biocompatible films can be adsorbed onto medical devices, where the
surface properties (e.g., wetting, hardness and lubricating ability) may be adjusted by
deposition o f polyion films. Fourth, biological cells can be encapsulated to block
unwanted recognitions. Fifth, drug delivery carriers can be made with controlled release
and targeting functions.

1.3.2BiocompatibIe Ultrathin Films
Biocompatible films are composed of multilayer assemblies o f natural polyions,
such as DNA, polynucleotides, and polysaccharides (e.g., heparin, chondroitine, and
chitosan). DNA and polynucleotides (polyuridylic and polyadenylic acids) can be readily
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assembled in alternation with polycations (PEI, PAH, polylysine) (Lvov, 1993a;
Sukhorukov, 1996). Polysaccharides with oppositely charged polyions can be assembled
on a surface to provide biocompatibilities. Cationic chitosan has been assembled with
anionic PSS at pH 4 (Lvov, 1998b). An albumin / heparin multilayer assembly for
biocompatible coatings was developed by Brynda (2000).
Polyions can also be assembled on biological surfaces. The technique overcomes
a fundamental obstacle preventing the use o f colloidal materials on biosurfaces: selfassembly onto a proteinaceous surface is hindered by the heterogeneity o f the chemical
groups on such surfaces. LbL polyion assembly covers heterogeneous surfaces and makes
them inert in biological liquids. The assembly o f a (poly(lysine) / alginate) multilayer on
a gelatin surface resulted in a 200-fold drop o f the adsorption o f human fibroblast cells,
as compared with the untreated surface (Elbert, 1999).

This approach would allow

treatment o f a limited area o f tissue via multiple rinsing steps with polyelectrolyte
solutions, thus generating a thin coating on tissue surfaces, and providing inherent
biocompatibility and degradability.
Biocompatible nanofilms formed on silicone rubber can provide a hydrophilic
surface (Ai, 2002c; Ai, 2002e; Ai, 2002d). Poly-D-lysine, gelatin, collagen, fibronectin,
and laminin were used in assembly o f films. Layer thickness varied from 1 nm to 4 nm as
monitored from QCM studies. The total film thickness was determined from the layer
numbers and the material composition. Films coated on silicone were hydrophilic
compared with unmodified silicone rubber, as verified from contact angle measurements.
Endothelial cells, nerve cells, and hepatocytes attached and grew on the films.
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Biocompatible films were patterned on a polydimethylsiloxane (PDMS) substrate
through micrcontact printing (Ai, 2002f). Patterning o f micro/nanospheres was achieved
with the layer-by-layer self-assembly technique.

Lines patterned

from 4.5-pm

microsphere and 45-nm nanosphere micropattem matched with the 60pm microchannels
from the PDMS stamp. The process differs from other methods for patterning self
assembled monolayers in that metal thin film coatings and alkanethiol solution were not
required.

PDMS

substrates

were

unmodified

before

stamping.

Polycation

poly(ethylenimine) and polyanion poly(styrenesulfonate) were used as ink solution to
form an ultrathin film on PDMS stamp through electrostatic LbL self-assembly. The
multilayer film o f (PEI/PSS)3/PEI was assembled with a thickness o f 12 nm. Then
negatively charged 4.5-pm microspheres or 45-nm fluorescence nanospheres were
adsorbed on the precursor film through the electrostatic interaction. Finally, microspheres
or nanospheres were patterned on the PDMS substrate through contact printing.
Positively charged poly-D-lysine was later adsorbed on negatively charged microspheres
to form patterned biocompatible films. Bovine coronary arterial endothelial cells were
attached on poly-D-lysine/microsphere patterns.
Biocompatible films assembled on microchannels increased cell adhesion and
growth on the sidewalls o f channels (Li, 2002). Using photolithography, ICP dry etching
and softlithgraphy, 100 pm channels were fabricated in PDMS. Gelatin nanofilms were
coated on the channels through LbL self-assembly. Smooth muscle cells were cultured on
PDMS flat surface as a control. Improved cell adhesion was observed on channels coated
with gelatin multilayers. Most cells grew along the channel sidewall. There was a
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significant difference in the alignment angle between the smooth muscle cells growing on
the flat surface and 100 pm channel (P<0.05).
Multilayer films which contain ordered layers o f protein species were assembled
by means o f alternate electrostatic adsorption mostly with positively charged PEI, PAH,
PDDA, chitosan or with negatively charged PSS, DNA and heparin (Lvov, 1995; Kong,
1999; Kong, 1994; Lvov, 1996; Hodak, 1997; Caruso, 1997; Caruso, 1998a; He, 1998;
Kong, 1998; Onda, 1999). The pH o f the protein solutions was set apart from the
isoelectric point so that proteins were sufficiently charged under the experimental
conditions. Water-soluble proteins, including, cytochrome c and P450, lysozyme, histone
type YIII-S, myoglobin (Mb), pepsin, horseradish peroxidase (POD), hemoglobin,
glucoamylase (GA), concanavalin A (Con A), albumin, glucose oxidase (GOx) (Kong,
1999; Hodak, 1997;), catalase, invertase, diaphorase (Kong, 1999; Lvov, 1996),
Bacteriorhodopsin (He, 1998), immunoglobulin IgG (Caruso, 1997; Caruso, 1998a) were
used at a concentration o f 0.1 - 2 mg/mL or ca. 10'5 M. The surface structure o f the solid
support can affect the stability o f proteins, and thus, precursor films o f alternate PEI/PSS
were used as standard surfaces.
All the proteins undergo the alternate adsorption with organic polyions for
unlimited numbers o f cycles. The mass increment at each step was reproducible. It is
noteworthy that the protein’s adsorption steps correlate with their molecular weights.
Protein layer thicknesses as estimated from X-ray reflectivity, or scanning electron
microscopy and molecular dimensions o f proteins show good correspondence, suggesting
a relatively uniform monolayer formation.
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Increased biological activity and enhanced stability o f polyions/proteins were
found in the films. Assembled proteins are in most cases not denatured (Kong, 1999;
Kong, 1994; Caruso, 1997; Kong, 1998). Proteins immobilized in multilayers with strong
polyions such as PSS, PEI, and PDDA were insoluble in buffer for a pH range between 3
and 10. Protein multilayers with weak polyions were partially soluble in solutions with a
pH close to the isoelectric point o f one o f the components (Brynda, 2000; Onda, 1999).
Moreover, in some cases layer-by-layer immobilization with linear or branched polyions
enhanced the enzymatic stability. The immobilization o f proteins in multilayers preserves
them from microbial attack. For example, the glucose oxidase/PEI multilayer was kept
for three months in a refrigerator at 5° C and preserved 90% o f its initial enzymatic
activity. Furthermore, glucose oxidase (GOx) in the multilayer with PEI was active up to
60° C, as compared with the 50° C GOx activity limit in solution (Onda, 1999). For the
antigen-antibody reaction in IgG / PSS multilayers, the activity increased up to 5 IgG
layers (Caruso, 1997). The compactness or openness o f protein multilayers may be
regulated. Glucose oxidase, myoglobin and albumin multilayer films were compact, but
IgG/PSS multilayers had an open structure with areas as large as 100 nm diameter
unfilled in the upper layers of the film (Caruso, 1998a).

1.3.3 Encapsulation of Micro/Nanotemplates
In the discussion above, polyelectrolytes, enzymes and nanoparticles were
assembled on a plane surface. The assembly process elaborated for a solid support may
be transferred for an assembly onto micro/nanotemplates such as porous carriers
(Pommersheim, 1994) or onto the surface o f charged particles with diameters o f 0.5 - 5
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microns (Caruso, 1998b; Caruso, 1999). The assembly o f organized polyion shells on
latex is promising for creation of complex catalytic particles. An assembly o f organized
protein shells on latex was recently demonstrated (Caruso, 1999). By alternate treatment
with poly(ethylenimine) (PEI) and polyacrylic acid (PAA) solutions at pH 6.5, the
multilayer shell o f (PEI/PAA)g was formed onto 500-p.m diameter acidic phosphatase /
alginate beads (Pommersheim, 1994).
Controlled releases o f dye (Antipov, 2001) and drug microcrystals were achieved
through nanoencapsulation (Qiu, 2001; Ai, 2002b; Ai, 2002g) with polyelectrolytes such
as PAH, PDDA, PSS, polysaccharides and polypeptides. Dye or drug release at different
pH environments was slowed after encapsulation and controlled through the shell
thickness. The permeability o f PAH/PSS multilayers o f the thickness of 20 nm for
fluorescein dye microparticles was about 10'9 m/s (Antipov, 2001). Charged polyions and
polypeptides were alternatively deposited on furosemide microcrystals through LbL
assembly (Ai, 2002b; Ai, 2002g; Ai, 2002e). The sequential deposition on the surfaces o f
furosemide particles o f PDDA and PSS was followed by adsorption o f polypeptides. The
release o f furosemide from the coated particles was measured in aqueous solutions o f pH
1.4 and pH 7.4. At both pH values, the release o f furosemide from the encapsulated
particles was slowed (10-300 times longer) as compared with unencapsulated furosemide.
The thickness o f the encapsulating membrane was ca. 115 nm for six bilayers o f
PSS/gelatin. The results provide a method to achieve prolonged drug release through selfassembly o f nano-materials on drug microcrystals.
Cells could also be used as micro templates for fabrication of nano-shells. Platelets
were coated with 78-nm silica nanoparticles, 45-nm fluorescent nanospheres, or bovine
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immunoglobulin G (IgG) through LbL assembly by alternate adsorption with oppositely
charged linear polyions (Ai, 2001a; Ai, 2002h; Ai, 2002a). Sequential deposition on
platelet surfaces o f cationic PDDA and anionic PSS was followed by adsorption of
nanoparticles or immunoglobulins. Nano-organized shells o f platelets were demonstrated
by TEM and fluorescence microscope images. Bovine IgG was assembled on platelets, as
verified with anti-bovine IgG-FITC labeling. Localized targeting o f anti-IgG shelled
platelets was also demonstrated. An ability to coat blood cells with nano-organized shells
can have applications in cardiovascular research and targeted drug delivery.
Bio/nanoreactors were fabricated by coating enzyme multilayers on nanosized
latex (Lvov, 2001a; Fang, 2002b; Fang, 2002a). Organized multilayers o f nanoparticles
(9-, 20-, 45-nm diameter silica or 12-nm magnetite) and glucose oxidase (GOx) were
assembled in alternation with oppositely charged polyelectrolytes on 420-nm latex
particles. Stepwise growth o f the multilayer films on latex was confirmed by
microelectrophoresis and transmission electron microscopy. The inclusion o f silica layers
on latex yields a higher surface area, resulting in greater GOx adsorption and thereby
increasing the catalytic activity o f the bio-reactor. The bioactivity was proportional to the
core surface area and also to the number o f GOx layers in the shells. Also the presence o f
magnetic nanoparticles allows self-stirring o f the nano reactors with rotating magnetic
field and enhances its productivity.
Nano-sized hollow shells were fabricated by dissolving cores encapsulated in
multilayers of polyelectrolytes (Caruso, 1998b). Shells were used as enzyme carriers
(Lvov, 2001b). Stable hollow polyelectrolyte capsules were produced by means o f the
LbL assembling o f PAH, and PSS, on melamine formaldehyde microcores followed by
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the core decomposition at low pH. These capsules are impermeable for urease in water
and become permeable in a water/ethanol mixture. The capsules were loaded with urease
in water/ethanol mixture and then resuspended in water. The urease molecules are kept in
the capsule, whereas the small urea molecules rapidly diffuse through the capsule wall
providing a substrate for the biocatalytic reaction.
In the enzyme crystal templating procedure, protein crystals (10-p.m diameter
catalase

or

0.2-jim

diameter a-chymotrypsin)

were

treated

sequentially

with

poly(styrenesulfonate) (PSS) and poly(allylamine) (PAH) or chitosan to form 5-8 layer
coverage (Caruso, 2000; Sukhorukov, 2000). The proteins were encapsulated in polyion
shells which are penetrable by small molecules (such as ions and low molecular weight
substrates), but which prevent protein leakage. By changing a solvent pH, nanocrystals
were dissolved that resulted in the formation o f spherical capsules containing a high
concentration (50 - 70 wt %) enzyme solution. Enzyme activity was retained in these
microcapsules, and the enzyme was stabilized against microbe attacks (Caruso, 2000).

1.4 Hypothesis and Specific Aims
1.4.1 Hypothesis
Nano-encapsulated platelets express lower activation and adhesion response
induced by high shear stress.

1.4.2 Study Objectives
A human coronary artery stenosis model will be built to test the hypothesis.
Endothelial cells will be seeded onto the inner surface of the model to simulate a
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physiological environment for the study o f platelet activation. Fixed and live platelets
will be coated with polyions, nanoparticles, and antibodies for assembly test. Live
platelets coated with an outermost layer o f heparin will be used in all flow studies.
Platelet activation and adhesion after encapsulation will be compared with unmodified
platelets. Overall platelet activation will be determined by TXB 2 assay. The amount of
nitric oxide released from endothelial cells will be determined from fluorescence nitric
oxide sensor. A cell viability/cytotoxicity fluorescence sensor will be used to label
platelets in order to measure the degree o f platelet adhesion on collagen.
Specific experiments are as following:
Flat silicone rubber substrates and the inner surface o f silicone model will be
coated with different nanofilms.
Fixed platelets will be encapsulated with polyions, nanoparticles, or antibodies.
Live platelets will be encapsulated with polyions and an outermost layer o f heparin. Cell
viability/cytotoxicity will be determined from a specific fluorescence sensor.
Laminar flow at a Reynolds number o f 436 will be imposed on the model. High
shear stress will be generated by a 90% area reduction stenosis, and the degree o f platelet
activation will be determined from TXB2 concentration after flow as a function o f the
maximum shear stress at the stenosis.
The nitric oxide released form endothelial cells at different locations will be
measured through a fluorescence nitric oxide sensor.
Models coated with a collagen nanofilm will be used to test platelet adhesion in
the flow experiment. Encapsulated and unmodified platelets will be labeled with a cell
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viability/cytotoxicity fluorescence sensor. The degree o f platelet adhesion is determined
from the fluorescence intensity difference before and after the flow experiment.
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CHAPTER 2

MATERIALS AND METHODS

2.1 Introduction
Activation and adhesion o f modified and unmodified platelets were studied under
flow conditions. Platelet solution was perfused through a 90% area reduction stenosis
coated with either collagen or endothelial cells. The 90% area reduction was selected to
provide a high shear stress, and the cosine shape was chosen because fluid dynamic data
were already available for this geometry.
Platelets were separated from the whole bovine blood by centrifugation. Layerby-layer self-assembly was used to modify the surface properties of the platelet. Platelet
viability and cytotoxicity after encapsulation were measured by using fluorescence
Live/Dead sensor. Overall platelet activation through the stenosis model was determined
by a Thromboxane B2 assay. Platelets were tagged with a fluorescent marker so that
adhesion onto the collagen-coated model could be measured from fluorescence intensity
change before and after each flow experiment. A fluorescence nitric oxide sensor was
used to quantify the nitric oxide released from endothelial cells in response to shear
stress.

31
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2.2 Coronary Artery Stenosis Silicone Model
2.2.1 Model Geometry
The flow model with an axisymmetric stenosis was designed to simulate the
stenosis coronary artery. The model had a diameter o f 6.35 mm with the stenosis
diameter o f 2.12 mm. The detailed geometry o f the stenosis model is shown in Figure
2.1. A 3-D view o f the model core is shown in Figure. 2.2.

±
D
T Is”

d
Ll

L2

L3

Figure 2.1 The core o f the stenosis model
Where D = 6.35 mm; d = 2.12 mm; LI = 63.50 mm; L2 = 19.05 mm; L3 = 165.10
mm

Figure 2.2 The 3-D view of the stenosis model
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The stenosis o f the model is cosine shaped with a 90% area reduction. The length
o f stenosis is nine times o f the diameter o f the minimum stenosis diameter (d). The shape
is described by:
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where
rs: the radius o f the stenosis
R: the radius o f the non-stenosis area
Z: the axial position from the greatest stenosis severity (zero value at the stenosis center)
D: the diameter o f the non-stenosis tube
A: the area o f the stenosis diameter (A = 0.1)

2.2.2 Casting the Coronary Artery Stenosis Model
The Aluminum (Alloy 7075 Aluminum, McMaster) model core was fabricated by
using an Optimum™ Ultra Precision Machining System. The flow model was
constructed by molding Sylgard 184 polymer (Dow Coming) around the core in a
Plexiglas box (Figure. 2.3a). To prepare the liquid silicone for casting, siloxane oligomers
and siloxane cross-linkers were mixed in a ratio o f 10:1 by weight. Any air bubbles in
silicone were removed with a vacuum pump. The mixed silicone liquid was then
carefully poured into the Plexiglas box. The silicone model cured to a solid state after
three days at room temperature (25°C), after which the model was removed from the
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Plexiglas box (Figure. 2.3b, c). Finally, the aluminum core was gently removed and the
cured silicone model was thoroughly rinsed with water.

Figure 2.3 The stenosis model of coronary artery
(a) Aluminum core in the casting box. (b) Core and cast model removed from the casting
box. (c) Close up o f b. The circular holes on the support platform are spaced 1 inch
apart.
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2.3 Silicone Surface Modification through Micro/
Nano-Film Coating
2.3.1 Gelatin-Glutaraldehvde Crosslinking on a
Flat Silicone Rubber Substrate
2.3.1.1 Silicone Rubber Substrate. A silicone (Sylgard 184, Dow Coming) rubber
film was coated on the bottom o f a 35 x 10 mm cell culture dish (Becton Dickinson).
Liquid silicone was prepared by the same process used for the flow model material. A
sample o f 0.5g o f freshly mixed liquid silicone was then added to each 35 * 10 mm
culture dish. The final solid substrate was formed after three days at room temperature.
2.3.1.2 Gelatin Crosslinking Methods. Two methods were used in the crosslinking
o f gelatin films on silicone rubber substrates. In the first method (Fig 2.4), gelatin powder
Type B o f bovine skin (Gloom 225, Sigma) and glutaraldehyde (GA) (Aldrich) were
mixed before coating. The ratio o f gelatin:GA is preferably from 256:1 to 64:1. To avoid
hydrolysis and loss of gel strength, gelatin solution was made freshly before the coating
procedure. In this study, three proportions o f 256:1, 128:1 and 64:1 were used. A gelatin
concentration of 5% was achieved in every final mixed solution. GA concentrations were
0.02%, 0.04%, and 0.08% in the different coating solutions. The silicone-coated 35 x 10
mm culture dishes with silicone coatings were pre-wetted with 100% ethanol, and then
washed twice with deionized water. The newly mixed solution was applied to the silicone
for 20 minutes at 27°C. The gelatin solution was poured from the dish and washed three
times with deionized water. A 1% Glycine (Sigma) solution was added, incubated for 30
min, and then washed 3 times with deionized water. Finally, the surface was washed once
with culture medium. A gelatin film formed after 5 hours in the flow hood.
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The second method (Method II) is illustrated in Fig. 2.1. The silicone surface was
pre-wet with 100% ethanol, and washed twice with deionized water. A 5% gelatin
solution was then added into culture dish, and allowed to sit for 40 min at 27°C, after
which the gelatin was poured from the dish. A 2.5 % glutaraldehyde solution was added
and incubated for 20 min. The gluteraldehyde was then discarded and the dish washed 3
times with deionized water. A 1% Glycine solution was then added, incubated for 30
min, and washed 3 times with deionized water. Culture medium was used to wash the
dish once as a final treatment. The gelatin film was ready to use after another 5 hours.

Gelatin/GA solution

I
Silicone
Gelatin solution

Silicone

n

Silicone

Glutaraldehyde

Washing &
Drying
Silicone

Silicone

Figure 2.4 Two methods of gelatin/GA crosslinking on a silicone rubber substrate

2.3.1.3

Gelatin Film Thickness. To determine the thickness o f gelatin/GA

crosslinking film coated on silicone rubber, Petri dishes were weighed on a scale before
and after the coating procedure. The gelatin/GA film thickness was calculated by using
the measured weight difference.
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2.3.1.4 Cell Culture. Clonetics® Endothelial Cell Basal Medium 500 ml (CC3121) was obtained from Cambrex Corp. Clonetics® Endothelial Cell Growth Medium
(CC-4133, Cambrex) contained 0.5 ml human epidermal growth factor, 0.5 ml
hydrocortisone, 0.5 ml 1000X Gentamicin sulfate - Amphotericin-B, 10 ml Fetal bovine
serum (FBS), and 2 ml Bovine Brain Extract (3 mg/ml protein content). The final media
was prepared by gently mixing CC-3121 and CC-4133 together before using. Bovine
coronary arterial endothelial cells (BCAEC) were obtained from a fresh bovine heart and
used after the second passage. BCAEC were obtained from a fresh bovine heart and used
after the second passage. The bovine coronary artery was rinsed three times with
phosphate buffered saline (PBS) to remove blood, then 0.25% collagenase solution was
injected into the artery and incubated for 30 minutes at 37°C in a CO 2 incubator.
Collagenase solution was then centrifuged at 1000 rpm to collect cells. Cell pellets were
dispersed in the media. Cells were cultured in a CO 2 incubator (Sanyo Scientific) under
95% air/5% CO 2 at 37°C in a humidified atmosphere. Cells were ready for use once
enough had accumulated. The seeding density was about 7.48 x 104 cells/cm2 on the
modified and unmodified silicone rubber surfaces.
2.3.1.5 Measurement of Contact Angle.To better understand the surface energy of
a modified silicone surface, contact angles were measured through the Sessile Drop
method. Measurements were taken when gelatin/GA crosslinked films formed after 24
hours. Deionized water drops were used in the measurement. For each surface, ten
measurements were collected.
2.3.1.6 Viscosity Study. To understand the gelatin-GA crosslinking process, the
viscosities o f gelatin-GA mixtures were dynamically measured at different time intervals.
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Gelatin and GA were mixed before the measurements. Because the exact amount o f GA
involved in method II was unknown, all samples used here were from method I. The
crosslinking occurred at room temperature (27°C). Before the measurements, the samples
were pre-heated in a water bath (Model TC-500, Brookfield) to 37°C. Viscosity was
measured on a digital viscometer (Model DV-II+ Version 3.2, Brookfield).

2.3.2 Coating Biocompatible Nanofilm on a Flat
Silicone Rubber Substrate
Cationic poly(ethyleneimine) (PEI, MW 25,000, Aldrich) and anionic sodium
poly(styrenesu!fonate) (PSS, MW 70,000, Aldrich) were selected for the LbL assembly.
To provide a physiological pH during the coating procedure, all preparation work was
performed in 0.01 M PBS solution at pH 7.4. Polypeptide such as poly-D-lysine (PDL)
and gelatin type B were got from Sigma. Vitrogen® Collagen type I was obtained from
Cohesion Technologies, Inc. Solutions o f 3 mg/mL PSS, 2 mg/mL PEI, 1 mg/mL PDL,
1mg/ml collagen, and 1 mg/mL gelatin were prepared in pH 7.4 PBS.
The CellTracker Green BODIFY (C-2102, Molecular Probes) is a probe that
freely passes through the cell membranes, but once inside the cell, it undergoes a
glutathione S-transferase-mediated reaction, producing a cell-impermeant reaction
product. Since glutathione levels in most cells are high (up to 10 mM) and glutathione
transferase is ubiquitous, this CellTracker reagent should provide an excellent means for
long-term studies o f cell viability and cytotoxicity. The reagent can be loaded into cells
by simply adding the CellTracker probe to the culture medium and then briefly washing
with fresh medium before analysis.
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2.3.2.1

Coating PEI/PSS Multilayers on PDMS. Three different films were coated

on silicone rubber for cell adhesion and growth. All films required a base that consisted
o f several layers o f PEI/PSS. These strongly charged polyelectrolytes PEI and PSS were
coated on the substrate through LbL self-assembly (Fig 2.5, method I). The silicone
substrates in the cell culture dishes were pre-wet with 75% ethanol, then rinsed with
deionized water twice. The surface was dried with nitrogen-gas. The first layer was
coated with 1mg/ml PSS solution for 30 minutes. Nitrogen gas drying and PBS washing
were performed before the second PEI coating. Further coatings were 15 minutes for
every layer with drying and PBS washing. The procedure was continued until the
required number o f layers was reached.

When cells were seeded directly onto PEI, 11

total layers were formed. When cells were ceded directly onto PSS, 12 total layers were
formed.
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Endothelial cells
Figure2.S Coating PEI/PSS film on silicone rubber substrate
2.3.2.2

Coating PEI/Gelatin Multilayers on Silicone Rubber.The procedure o f

coating biocompatible nanofilm on a flat silicone rubber substrate is briefly described in
Figure 2.5 (method 2). A precursor film o f (PSS/PEI) 2 + PSS was assembled by the
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procedure outlined in the previous section.

Multilayers o f (PEI/Gelatin)s were then

coated on the precursor layer through the electrostatic LbL self-assembly. The coating
method was similar to the precursor layers, but a longer incubation time (30 minutes) for
gelatin was required. A film with the architecture o f (PSS/PEI)2 + PSS + (PEI/Gelatin )5
was formed on the silicone rubber substrate through LbL self-assembly.
2.3.23 Coating PDL/Gelatin Multilayers on Silicone Rubber.The procedure o f
coating biocompatible nanofilm on a flat silicone rubber substrate is briefly described in
Figure 2.5 (method 2). A precursor film o f (PSS/PEI) 2 + PSS was assembled by the
procedure already described. Then multilayers o f (PDL/Gelatin)s were coated on the
precursor layer through the electrostatic LbL self-assembly. Again, 30 minutes o f coating
was required for the gelatin was required. The final film architecture was (PSS/PEI) 2 +
PSS + (PDL/Gelatin)5.
2.3.2.4

Coating PSS/Collagen Multilayers on Silicone Rubber. The procedure o f

coating biocompatible nanofilm on a flat silicone rubber substrate is briefly described in
Figure 2.6. A precursor film o f (PSS/PEI) 2 was deposited on the silicone rubber by the
previously described coating procedures. The collagen used here was type I (Vitrogen,
Cohesion Technologies, Inc). A solution o f 1 mg/ml collagen was used in the assembly
procedure. Multilayers o f (PSS/Collagen)s were coated on the precursor layer through the
electrostatic LbL self-assembly, allowing 30 minutes for each collagen layer. The final
film architecture was (PSS/PEI)2 + (PSS/Collagen)s.
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Figure2.6 Coating PSS/CoIIagen film on PDMS substrate
2.3.2.5 Measurement of Contact Angle. To better understand the surface energy
o f a modified silicone surface, contact angles were measured through the Sessile Drop
method. Measurements were taken after every layer was coated and dried. Deionized
water drops were used in the measurement.
2.3.2.6 Monitoring the Thickness o f A Nanofilm. To monitor polyion layer
formation on silicone rubber at pH 7.4, the coating procedure was elaborated on 9-MHz
quartz crystal microbalance (QCM, USI-System Inc, Japan) electrodes. The QCM
frequency shift (AF) caused by the stepwise adsorption process was measured. The mass
and thickness o f each assembled layer was derived from AF. For these calculations, the
Sauerbrey equation (Sauerbrey 1959) was used with the scaling method o f Lvov (Lvov
1995).

2.3.3 Coating a Collagen Nanofilm onto the Inner
Surface of a Silicone Model
Platelet adhesion on collagen substrate was carried out in the coronary artery
stenosis silicone model. Collagen/polyion film was coated on the inner surface of a

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

stenosis model through LbL self-assembly (Fig 2.7). The silicone model was first rinsed
with deionized water twice. Then one ending o f the model was sealed with a stopper.
3mg/ml PSS solution was gradually added into the model and incubated for 30 minutes.
PSS solution was discarded after coating and rinsed three times with deionized water.
Gentle nitrogen gas drying was performed to remove the remained water inside the
model. Coating the second layer o f PEI was sim ilar to the first layer. Washing and drying
was necessary before the third layer coating. A precursor film o f (PSS/PEI) 2 was
assembled on the inner surface o f the silicone model after repeating the previous coating
procedures. Then multilayers o f (PSS/Collagen )5 were coated on the precursor layer
through the electrostatic LbL self-assembly. The coating method was similar to the
precursor layers, but forming a complete collagen layer required a 30-minute exposure to
the collagen.

The final film architecture was (PSS/PEI) 2 + (PSS/Collagen)s was formed

on the inner surface o f a silicone model. The model was sterilized with 10 X Gentamicin
solution (Sigma) and was dried with nitrogen gas before use.
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(PSS/Collagen)5
(PSS/PEI)2

Silicone tubing
Figure 2.7 Cross-sectional view of a collagen nanofilm coated on the inner surface of
a silicone model.

2.3.4 Seeding Endothelial Cells onto the Gelatin
Nanofilm Coated on the Silicone Rubber Substrate
2.3.4.1 Cell Adhesion and Growth on PEI/gelatin Nano film. A PEI/Gelatin film
was coated on the silicone rubber through LbL self-assembly as described before (Figure
2.8). Endothelial cells were seeded on the nanofilm to test the film biocompatibility. The
precursor layer o f (PSS/PEI) 3 + PSS was first coated on the silicone rubber substrate. A
(PEI/gelatin )5 multilayer was further assembled on the precursor layer to form the
nanofilm. Cells were seeded onto the nano film-covered silicone rubber substrate with a
density o f 3.6 x 105 cells/cm2.
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Figure 2.8 Seeding endothelial cells on PEI/Gelatin nanofilm coated on silicone
rubber substrate

2.3.4.2

Cell Adhesion and Growth on PDL/gelatin Nanofilm. The film composed

o f (PDL/gelatin) multilayers was coated on the PDMS substrate and endothelial cell
seeding was performed.
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Figure 2.9 Seeding endothelial cells on PDL/Gelatin nanofilm coated on silicone
rubber substrate

2.3.5 Seeding Endothelial Cells on the Inner Surface
of Silicone Model
The inner surface o f a silicone model was modified for endothelial cells adhesion
and growth. An ultrathin film composed o f PDL/Gelatin multilayers was coated on the
inner surface o f a stenosis model through LbL self-assembly (Figure 2.10). The silicone
model was first rinsed with deionized water twice. Then one end o f the model was sealed
with a stopper. A 3 mg/ml PSS solution was gradually added into the model and
incubated for 30 minutes. The PSS solution was discarded after coating and rinsed three

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

47

times with deionized water. Nitrogen-gas drying was performed to remove the remaining
water inside the model. Then a polycation layer o f PEI was assembled on the PSS layer.
Washing and drying was necessary between assembling every two layers. A precursor
film o f (PSS/PEI) 2 + PSS was assembled on the inner surface o f the silicone model after
repeating the previous coating procedures. Then multilayers o f (PDL/Gelatin )5 were
further coated on the precursor layer through the electrostatic LbL self-assembly. The
final film architecture was (PSS/PEI) 2 + PSS + (PDL/Gelatin)5 - The model was sterilized
with 10 X Gentamicin solution and dried with nitrogen gas before using.

--------- (Gelatin/PEI)5/Gelatin
——

(PSS/PEI)2

Silicone tubing
Figure 2.10 The cross-section view of a silicone model with inner surface coverage of
endothelial cells

Before cell seeding, the model was rinsed with cell culture media once.
Endothelial cells with a seeding density o f 4.2 x 105 cells/cm 2 were incubated in the
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model in a CO 2 cell culture incubator. The model was turned manually from one side to
another every hour after seeding. After eight hours o f seeding, a flow system with media
supply was hooked up with the model (Figure 2.11). The system is composed o f a
silicone model, a variable speed pump (Fisher Scientific, Model NO. 13-876-2), and a
bottle o f culture media. Silicone tubing was used to connect all parts o f the system. Cell
adhesion on the inner surface o f the model is more stable after pre-treated with low shear
stress flow (Dardik, 1999). The seeded model was treated for 24 hours with 1 dyne/cm 2
shear stress before running the platelet solution.

Flow D irection

(T) Tubing
(2 ) S tenosis Model
( 3) Pump
( 4 ) Culture Media
(5 ) Stopper

Figure 2.11 Culture endothelial cells in a flow system

2.4 Nano-Encapsulation of Platelets

2.4.1 Nano-Encapsulation of Fixed Platelets
2.4.1.1

Reagents

and

Materials.

Cationic

poly(dimethyldiallylammonium

chloride) (PDDA, MW 200,000, Aldrich) and anionic sodium poly(styrenesulfonate)
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(PSS, MW 70,000, Aldrich) were selected for the LbL assembly. To provide a
physiological environment during the coating procedure, all preparation work was
performed in 0.01 M PBS solution at pH 7.4. Silica nanoparticles o f 78-nm diameter
(Nissan Chemical Industries, Japan) and yellow-green fluorescence nanospheres (FN) of
45-nm diameter (Polysciences, Inc) were used for the assembly. PSS, silica and FN are
negatively charged, while PDDA is positively charged at pH 7.4. Solutions o f 3 mg/mL
PSS, 2 mg/mL PDDA, 10 mg/mL silica, and 2.5 mg/mL FN were prepared in pH 7.4
PBS. Solutions o f 0.5 mg/mL bovine IgG (Sigma) and 0.2 mg/mL anti-bovine IgG-FITC
(Sigma) were used.
2.4.1.2 Platelets. Platelets were purified from fresh bovine blood. Platelet rich
plasma (PRP) was obtained through centrifugation (Eppendorf 5804R centrifuge) at 250
g for 20 minutes at 22°C. Immediate fixation o f PRP in 1% paraformaldehyde solution
was carried out for two hours. Platelets were further purified by centrifugation at 500 g
for 5 minutes and dispersed in phosphate buffered saline (PBS). The final platelet
concentration was ca.

2

x 1 09 /mL.

2.4.1.3 Instrumentation. An Eppendorf 5804R centrifuge was used for the shell
assembly. A quartz crystal microbalance, transmission electron microscope (TEM,
Philips-CMIO, Netherlands) and fluorescent microscope (Nikon, Eclipse, 2000) were
used for structural analysis of the nano-ensembles.
2.4.1.4

Platelets

Nano-Assembly.

It

is

important

to

apply

linear

polycation/polyanion layers on microtemplates before assembly o f proteins and
nanoparticles. Flexible linear polyions cover the cell surface and act as “electrostatic
glue” which holds oppositely charged nanoparticles or antibodies. A platelet surface is
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negatively charged because most platelet surface glycoproteins have isoelectric points
lower than 7.4 (McGregor, 1980). Figure 2.12 shows three methods o f an assembly to
functionalize platelet shells. In route (A), the outermost layers o f FN/PDDA/FN were
assembled by alternation o f negatively charged fluorescent latex with positively charged
PDDA. In route (B), a Silica/PDDA/Silica shell was deposited. For both methods, an
additional outermost layer o f PDDA was assembled as a protection layer (to prevent loss
o f silica or fluorescent nanoparticles). In route (C), an immunoglobulin bilayer of
composition (PSS/IgG)? was assembled.

Polyions

B ovine IgG
A n ti-b o v in e IgG-FITC

Silica

B ovine IgG

<\XkW

A nti-bovine
IgG-FITC

Figure 2.12 Scheme o f three methods of an assembly to functionalize platelet shells

Next, bovine IgG was deposited through LbL self-assembly at a specific area in
the silicone tubing, and the other parts o f the tube remained uncovered with IgG (Figure.
2.13). One tenth o f the length

(8

mm) o f protein-deposition-resistant silicone medical
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tubing was selectively coated with bovine IgG on the inner surface. A solution of
platelets shelled with anti-bovine IgG-FITC was then passed through the tubing 20 times.
Afterwards, the tubing was rinsed, dried, and studied under a fluorescence microscope.

Silicone tubing

Anti-bovine IgG-FITC
encapsulated platelets
Bovine IgG coated area
Figure 2.13 Anti-bovine IgG-FITC encapsulated platelets targeting to the IgG
coated area

Positively charged PDDA was first deposited on the platelets. Adsorption was
allowed to proceed for 20 minutes to ensure complete coverage. Platelets were separated
from the PDDA solution by centrifugation at 550 g for 5 minutes. After three washing
cycles, a layer o f PSS was assembled. The adsorption procedure was similar to that used
for the PDDA layer. A PDDA/PSS/PDDA multilayer was assembled on platelets as a
precursor before deposition o f nanoparticles or IgG.
To monitor polyion and nanoparticle layer formation on platelets at pH 7.4, the
coating procedure was elaborated on 9-MHz QCM electrodes. The QCM frequency shift
(AF) caused by the stepwise adsorption process was measured and used to calculate mass
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and thickness o f the layers deposited at every assembly step. For these calculations, the
Sauerbrey equation was used (Sauerbrey, 1959) and scaling was performed (Lvov, 1995).

2.4.2 Nano-Encapsulation of Live Platelets
In contrast to the previous approach, platelets were also assembled with nano
shells while alive. Two layers were assembled on live platelets (Figure. 2.14). Platelets
were first exposed with positively charged polyion PDDA for 5 minutes and then washed.
Then polysaccharide heparin was assembled as the outermost layer. Adsorption o f a
PDDA/heparin multilayer on QCM electrodes was used as an indirect measure o f shell
formation on platelets.

PDDA
Heparin

Platelet

Polycation
(PDDA+)

Polyanion
(H eparin)

Figure 2.14 Live platelets assembly

2.4.2.1

Platelet Live/Dead Viability and Cytotoxicity Analysis. The LIVE/DEAD

® Viability/Cytotoxicity Assay Kit (Molecular Probes, L-3224) provides a two-color
fluorescence cell viability assay that is based on the simultaneous determination o f live
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and dead cells with two probes that measure two recognized parameters o f cell viabilityintracellular esterase activity and plasma membrane integrity. It has been shown that
calcein AM and ethidium homodimer (EthD-1) are optimal dyes for this application
(Papadopoulos, 1994). This method is generally faster, cheaper, safer and a more
sensitive indicator of cytotoxic events than alternative methods. The assay has been used
to quantify apototic cell death (Jacobsen, 1996) and cell-mediated cytotoxicity
(Papadopoulos, 1994). The amount o f live and dead/damaged cells were counted by using
a fluorometer.
2.4.2.2

Labeling Procedure. The following procedure is used to label the cells for

live/dead analysis:
1. Remove the LIVE/DEAD reagent stock solutions from the freezer and allow them
to warm to room temperature.
2. Add 20 pL o f the 2 mM EthD-1 stock solution (Component B) to 10 mL o f sterile
PBS, vortexing to ensure thorough mixing. This procedure creates an
approximately 4 pM EthD-1 solution.
3. Combine the reagents by transferring 5 pL of the supplied 4 mM calcein AM
stock solution (Component A) to the 10 mL EthD-1 solution. Vortex the resulting
solution to ensure thorough mixing. The final solution contains approximately 2
pM calcein AM and 4 pM EthD-1.
4. Redisperse the encapsulated platelets in the final working solution and incubate
for 30 minutes at room temperature.
5. Following incubation, add 20 pL o f the platelet solution on a clean microscope
slide.
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6

. For quantitative assay, add 1 ml o f 10 times diluted platelet solution into the
fluorometer cell and record the reading at corresponding wavelengths. The
excitation wavelength for live platelets labeled with Calcein is 494 nm.

The

emission wavelength is 517 nm. For dead platelets labeled with EthD-1, the
excitation wavelength is 528 nm, and the emission wavelength is 617 nm.

2.5 Model Setup
The setup of the model in a flow system is shown in Figure 2.15. The syringe is
driven by a self-made syringe pump. The syringe pump is composed o f a speed control
box, a motor (SLO-SYN Synchronous/Stepping Motors, Superior Electronic, Part No.
M062-LF-402F), an Adjustable DC power supply (PSA-305, Samlex Electric Company
Ltd), and a Triple output DC power supply (E3630A, Hewlett Packard). Nalgene 50
Silicone Tubing (Nalge Company, Model NO. 8060-0060) was used in connecting the
model and the syringe. A 60 ml syringe (Becton Dickinson) was used to inject the platelet
solution into the model. The syringe can be pushed forward or backward by the stepper
motor according to the control settings. The Reynolds number o f coronary artery blood
flow is calculated by using the following equation:

Re = i^ 2 .,
k

D/ u

where
Q: Flow rate
p: Density of fluid
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D: Diameter o f the blood vessel or silicone model
|_l: Viscosity o f fluid
Here, we used the following numbers for related parameters as a simulation o f
human coronary artery blood flow. For a typical coronary artery, the flow rate o f
coronary artery blood flow, density o f blood, diameter o f coronary artery, and viscosity
o f blood are 4 cm 3 /sec, 1.05 g/cm3, 0.35 cm, and 0.035 g/s'lcm‘' respectively. The
corresponding Reynolds number o f the coronary artery flow is 436. The same Reynolds
number was kept in our silicone coronary artery stenosis model. The platelet solution has
a viscosity o f 0.01 g/s"1cm‘I and a density o f 1.01 g/cm3. The diameter o f non-stenosed
section o f the model is 0.635 cm. The corresponding flow rate in the silicone flow model
is 2.15 cm 3/sec, and the velocity o f inlet flow is 6.78 cm/sec.
Platelet solution was injected into the model by the syringe, and a hemostat (3)
was used to stop the flow into the side branch direction. The hemostat was released when
the fluid was returned to the syringe so that the solution would not pass backwards
through the model. The platelet solution was then re-injected into the model by the
syringe under the same flow condition. In all, 20 injections were performed. The
experiment was carried out inside a sterile flow hood. The stenosis model, tubing, and the
syringe were all sterilized by 10 X Gentamicin solution before the onset o f flow.
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Flow Directi on
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(T) Tubing

©

(2 ) Stenosis Model
(3 ) Hemostat
(4 ) Syringe
(5 ) Syringe Pump
(T) Mount

Figure 2.15 The setup o f a stenosis model in a flow system

2.6 Thromboxane B? Measurement through ELISA
Samples o f platelet solution were obtained after the flow experiment for
measurement o f thromboxane B 2 concentration. An Enzyme-Linked Immunosorbent
Assay (ELISA) was performed to determine the amount o f TXB 2 released from platelets.

2.6.1 Contents of the Assay System
The assay system contained the following:
Microtitre plate. Plate contains 1 2 X 8 well strips cotaed with donkey anti-rabbit
IgG.
Thromboxane

B2

peroxidase

conjugate.

Thromboxane

peroxidase, lyophilized.
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Thromboxane B2 standard. Thromboxane B2 2.56 ng, lyophilized.
Antiserum. Rabbit anti-thromboxane B2, lyophilized.
TMB substrate. Enzyme substrate containing 3,3’, 5,5’-tetramethylbenzidine
(TMB)/hydrogen peroxide in dimethylformamide.
Assay buffer concentrate. Assay buffer concentrate, 5 ml. On dilution this bottle
contains 0.1 M phosphate buffer, pH 7.5 containing 0.9% NaCl and 0.1% bovine serum
albumin and preservative.
Wash buffer concentrate. Wash buffer concentrate of 12.5 ml. On dilution the
reagent contains 0.01 M phosphate buffer, pH 7.5 containing 0.05% Tween™20.
The detailed assay protocol is described in Figure 2.16.

Solid phase

I

Assay reagent

Standard or unknown

I

I

Substrate

I

TXBj

TXBj peroxidase +

TMB

Weil

Stop reaction
measure OD

< ------------------------------------------------------------------------------► <4--------------------------►

Incubation 1 hour

Incubation 15min

Figure 2.16 TXB 2 measurement through ELISA (modified from BIOTRAK, 1994)

A 1 ml sample o f concentrated platelets was added into a centrifuge tube (tube I),
mixed with 2 ml acetone, and shaken for 2 min. The mixture was then centrifuged at 4°C
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(12,000 g, 3 mm). The supemant was transferred to a second tube (tube II), and 2 ml
hexane was added. This tube was shaken for 2 min and centrifuged at 4°C for 5 min at
12,000 g. The upper hexane layer was discarded and the pH o f the lower layer was
adjusted to 3.0 ~ 4.0 with 1M citric acid. After addition o f 2 ml chloroform, the tube was
shaken for 2 min, and centrifuged at 4°C for 5 min at 12,000 g. The lower chloroform
layer contained the extracted TXB2. The super layer was collected into a third tube (tube
III) and extracted again with 2 ml chloroform. The super layer o f tube III was discarded.
The extracts from tube II and III were dried under nitrogen or vacuum.

2.6.2 Enzvmeimmunoassav Procedure
2.6.2.1

Reagent Preparation. All reagents must be allowed to equilibrate to room

temperatures before use.
Assay Buffer. Transfer the previous extracts to a 50 ml graduated cylinder by
repeated washing with distilled water. Adjust the final volume to 50 ml with distilled
water and mix thoroughly.
Standard. Carefully add 2.0 ml diluted assay buffer add replace the stopper. Mix
the contents o f the bottle until completely dissolved.
Thromboxane B 2 peroxidase conjugate. Add 6.0 ml diluted assay buffer and
replace the stopper. Mix the contents o f the bottle until completely dissolved. The
solution will contain thromboxane B2 -horseradish peorxidase in phosphate buffer
containing 0.9% sodium chloride, 0.1% bovine serum albumin and preservative.
Antiserum. Add 6 ml diluted assay buffer and replace the stopper. Gently mix the
contents o f the bottle until a complete solution is obtained. The solution will contain anti
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thromboxane B2 serum in phosphate buffer containing 0.9% sodium chloride, 0.1%
bovine serum albumin and preservative.
2.6.2.2 Preparation o f Working Standards. Eight different working standard
concentrations were prepared from 0.5 pg to 64pg. Label 7 centrifuge tubes 0.5pg, lpg,
2pg, 4pg, 8 pg, 16pg, and 32 pg. Pipette 500 pi assay buffer into all tubes. Pipette 500 pi
o f the stock standard (1.28 ng/ml) into the 32 pg tube and mix thoroughly. Transfer 500
pi from the 32 pg tube to the 16 pg tube and mix thoroughly. Repeat this doubling
dilution successively with the remaining tubes. Aliquots o f 50 pi from each serial dilution
together with the stock solution will give rise to

8

standard levels o f TXB 2 ranging from

0.5 to 64 pg per well.
2.6.2.3 Assay Protocol. The detailed assay protocol is summarized in the
following table.

Five mixtures are prepared, a substrate blank, a test for nonspecific

binding, a zero standard, thromboxane B2 standards, and the test samples. To prepare
each sample, the reagent listed on the left hand column o f the table is mixed in the
indicated amount and order.
Table 2.1 Thromboxane B2 Enzymeimmunoassay Protocol (volume unit: pi)

Reagent
Buffer
Standard
Sample
Antiserum
Conjugate*

Substrate
blank
—

—

—
—

—

Assay Mixture
Standards
Non
Zero
specific
standard
binding (N) (Bo)
100
50
50
—
50
50
50
50
50
—

—

—

—

—

—
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Samples

—

—
50
50
50

60

Table 2.1 continued.
Cover the plate, and incubate at room temperature (15°C) for I hour while shaking.
Aspirate and wash all wells four times with 400 pi wash buffer. Immediately dispense
150 pi TMB substrate into all wells.
TMB
substrate

150

150

150

150

150

Cover the plate and mix on a microtitre plate shaker for exactly 15 minutes.
1M
Sulphuric
acid**

100

100

100

100

100

Shake to mix contents and determine optical density at 450 nm within 30 minutes.
*: Thromboxane B2 peroxidase conjugate
**: 1M sulphuric acid was used to stop the reaction
2.6.2.4

Calculation o f Results. The percent bound for each standard and sample

was calculated by using the following equation.

B. o/o = (San1p le-O rjtandar^O D_-NO D) 100
B0
BOOD - NOD
where
OD: optical density
NOD: optical density o f non-specific binding
BOOD: optical density o f the zero standard

2.7 Platelet Adhesion Test
Sample platelet solution before and after the flow experiment was collected for
platelet adhesion analysis. Before running through the stenosis model, encapsulated and
unmodified platelets were labeled with LIVE/DEAD ® Viability/Cytotoxicity Assay Kit.
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Then fluorescence intensity o f both samples was measured. After the flow experiment,
samples were collected and again measured the fluorescence intensity. In every
measurement, 494-nm excitation was used, and the component at 517 nm in the emission
spectrum was measured.

2.8 Nitric Oxide Fluorescence Sensor
Nitric oxide from endothelial cells was measured with a fluorescence sensor
DAF-FM diacetate (Molecular Probes, D-23842). The compounds, developed by Kojima
and collaborators (Kojima, 1998), are essentially nonfluorescent until they react with NO
to form a fluorescent benzotriazole (Figure 2.16). DAF-FM diacetate is cell-permeant and
passively diffuses across cellular membranes. When inside cells, it is de-acetylated by
intracellular esterases to become DAF-FM. The fluorescence quantum yield o f DAF-FM
is -0.005, but after reacting with nitric oxide, it increases about 160-fold, to —0.81
(Kojima, 1999). The excitation and emission wavelengths o f DAF-FM are 495 nm and
515 nm, respectively. The spectra o f the NO adduct o f DAF-FM are independent o f pH
above pH 5.5 (Kojima, 1999). Also, the NO adduct o f DAF-FM is photostable for image
capture. Finally, DAF-FM is highly sensitive for NO with a detection limit o f 3 nM.

o
c-o

DAF-FM d H U m
flfan fcat—

itM J pan w n f l

NO*

DAF-FM
W M ftftrftM M M anO

c-o

Benzotriaznle derivative
<nfaWMMO0

Figure 2.17 Reaction scheme for the detection o f nitric oxide (NO) by DAF-FM and
DAF-FM diacetate
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A 5 mM stock solution o f DAF-FM diacetate (D-23842, 1 mg) with a molecular
weight o f 496.42 was prepared in 0.4 ml anhydrous DMSO. Then 20 pi aliquots were
added in a centrifuge tube and stored at -20°C. The final working solution was 5 pM as
diluted 1000 times in PBS from the stock solution.
The silicone model coated with endothelial cells was first incubated with working
DAF-FM diacetate solution for 30 minutes. Then the solution was discarded, and the
platelet solution was driven through the model by the syringe pump. Finally, the model
was rinsed with PBS, and cut into five parts (Figure. 2.17). Endothelial cells were peeled
o ff from the model by using trypsin solution. Cells were collected by centrifuge at 1000
rpm and redispersed in a 0.5 ml PBS solution. The number of cells was counted by using
a hemacytometer. A total o f 106 cells from every sample was used for analysis.
Endothelial cells cultured in Petri dish without DAF-FM diacetate incubation were used
as a negative control. All samples were analyzed by flow cytometry. The number of cells
was counted by using a hemacytometer (C.A. Hausser & Son). Finally, the intensity of
fluorescence signal was calculated based on the number o f cells per region.

rEndothelial cells

Figure 2.18 Regions of endothelial cells used for NO release measurement
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2.9 Data Analysis
In the platelet targeting experiment, a MatLab image-processing program was
used to analyze the area o f targeted platelets. In every platelet activation and adhesion
experiment, unmodified and encapsulated platelets were from the same blood source. The
paired T test (a = 0.05) was used to analyze thromboxane B2 level and platelet adhesion
results.
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CHAPTER 3

RESULTS

3.1 Silicone Surface Modification for Endothelial
Cell Adhesion and Growth
3.1.1 Gelatin-Glutaraldehvde Crosslinking on Silicone
Rubber for Cell Adhesion and Growth
3.1.1.1

Gelatin Film Thickness. The approximate gelatin film thickness was

calculated from the amount o f gelatin/GA crosslinked on silicone rubber substrates, the
bottom area o f a Petri dish, and the density o f gelatin. The thickness o f a gelatin film was
in the range o f 110 ~ 160 pm. The detailed film thickness is listed in Table 3.1.

Table 3.1 The Thickness o f Gelatin/GA Crosslinked Films
Methods

METHOD I

Thickness (pm)
138.5 ± 15.3

Gelatin:GA = 64:1

132.2 ±24.1

G elatin:G A = 128:1

METHOD II

Gelatin:GA = 256:1

135.0 ± 17.4

5% Gelatin, 2.5% GA

143.0 ±27.6

64
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The gelatin/GA (Gelatin:GA = 64:1) crosslinking resulted in a film thickness o f
138.5 ± 15.3 jam on silicone rubber. The film thickness was 132.2 ± 24.1 pm and 135.0 ±
17.4 (jm for gelatin:GA = 128:1 and gelatin:GA = 256:1 respectively. There was no
significant difference among three groups, so the amount o f gelatin remaining onto
silicone rubber substrates was dependent on different GA concentrations. In method II,
the gelatin film thickness was 143.0 ± 27.6 pm, and there was no statistically significant
difference from method I.
3.1.1.2

Contact Angle. The surface properties o f unmodified silicone rubber and

gelatin-coated silicone rubber were characterized through contact angle measurements.
Usually a lower contact angle represents a hydrophilic surface. Membranes formed on
silicone rubber through gelatin/GA crosslinking displayed significantly lowered contact
angles (p<0.01). The unmodified silicone rubber surface was hydrophobic with a contact
angle o f 107 ± 1.1° (Figure 3.1). In the first method, the contact angles o f gelatin
modified surfaces were 84 ± 1.1°, 77.2 ± 1.6°, and 75.1 ± 1.9° for gelatin:GA of 256:1,
128:1, and 64:1, respectively. Crosslinking o f gelatin:GA = 64:1 on silicone mbber has
the lowest contact angle and is thus the most hydrophilic o f the three surfaces modified
by method I. The contact angle measured on method II gelatin/GA crosslinking modified
surface was 73.3 ± 1.1°. It is hydrophilic but no significant difference was found when
compared with method I gelatin:GA = 64:1. All these modified surfaces are significantly
hydrophilic in comparison to unmodified silicone (p< 0 .0 1 ).
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Different Surfaces
Figure 3.1 Contact angles o f different surfaces. The contact angle on the unmodified
silicone rubber is 107 ± 1.1°
All modified surfaces are hydrophilic. In method I, the contact angles o f gelatin modified
surfaces were 84 ± 1.1°, 77.2 ± 1.6°, and 75.1 ± 1.9° for gelatin:GA o f 256:1, 128:1, and
64:1, respectively. The contact angle on method II modified silicone rubber is 73.3 ±
1. 1°.

3.1.1.3

Viscosity Study. Gelatin/GA crosslinking was observed as the liquid

solution solidified during the gelation procedure. Viscosity o f gelatin/GA mixtures was
used as a measure o f crosslinking (Figure 3.2). In the shortest amount o f time (45
minutes), gelatin:GA = 64:1 solution turned to a solid gel status. For 0.08% GA
concentration (gelatin:GA = 64:1), viscosity was recorded every five minutes for a total
period o f 45 minutes. The initial viscosity was 4.56 mPa-s and 17.5 mPa-s at 30 minutes.
The viscosity increased exponentially to 190.4 mPa-s at 35 minutes. Finally, it reached
513 mPa-s at 45 minutes. Readings could not be taken at 50 minutes since the mixture
had already gelled. The gelatin:GA = 128:1 did not gel as quickly as the 64:1 solution
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and was not in a complete solid state after 5 hours. The viscosity increased slowly with
time. The final viscosity was 71.8 mPa-s. So 0.04% GA concentration in crosslinking was
in a less degree compared with 0.08% GA concentration. The viscosity o f 0.02% GA
(gelatinrGA = 256:1) varied slightly after 5 hours. The initial viscosity was 4.1 mPa-s and
the final viscosity was

6 .8

mPa-s. The solution was still in a liquid status. The viscosity

o f the method II solution was not measured here because it was not known how much GA
reacted with gelatin. Viscosity o f 5% gelatin solution was measured as a comparison to
those crosslinked solutions. The viscosity was stable around 2 mPa-s during 5 hours o f
measurement.

000
— B - - G ela tin :G A = 256:1
— A — G ela tin :G A = 128:1
— 0 — G ela tin :G A = 64:1
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Figure 3.2 Viscosity measurements of different gelatin solutions
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3.1.1.4

Endothelial Cell Adhesion and Growth. Endothelial cell attachment and

growth were observed at 4 hours, 12 hours, 24 hours, 48 hours and 72 hours after
seeding. Here, photos taken at 72 hours are shown for comparison among different
silicone rubber surface modifications. The initial seeding density is 7.48 x 104 cells/cm2.
After 72 hours o f seeding, the cell density was about 1.09 ± 0.26 x 105 cells/cm2, 1.00 ±
0.23 x 105 cells/cm 2 and 5.13 ±

0 .1 2

x 104 cells/cm 2 for method I with GA concentration

o f 0.08%, 0.04% and 0.02%, respectively. On the modified surface provided by method
II, the cell density was about 8.82 ± 0.08 x 104 cells/cm2. Some cell adhesion was found
on silicone rubber.
At 4 hours after seeding, cells were partially attached to the modified and
unmodified surfaces. At 12 hours, cells on modified surfaces were all well attached and
growing, while most o f the cells on silicone surface were detached and clumped together.
At 24 hours, cells on all gelatin-modified surfaces were growing well. Minimal cell
attachment on silicone was observed. After 48 hours, no cell attachment was observed on
unmodified silicone rubber, and some cell fragments were seen in the media. While all
cells were attached onto the modified surfaces.
At 72 hours (3 days) after seeding, cells were growing well on the method I (GA
concentrations o f 0.04% and 0.08%) modified surface (Figure 3.3a & b) and the method
II modified surface (Figure 3.4). Cells attached on the above surfaces were in round or
oval shapes usually indicating good adhesion and growth. On the method I (GA: 0.02%)
modified silicone surface, cells were differentiated after 72 hours (Figure 3.3c) indicating
bad adhesion. Almost no cell adhesion was found on the unmodified silicone surface
(Figure 3.5).
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Figure 3.3a Cells attached on method I (GA: 0.08%) modified surface at 72 hours
Cells were well attached on the gelatin/GA modified silicone rubber substrate
(Magnification: x 200).

Figure 3.3b Cells attached on method I (GA: 0.04%) modified surface at 72 hours
Endothelial cells covered most areas and in a subconfluent state (Magnification: x 200).

Figure 3.3c Cells attached on method I (GA: 0.02%) modified surface at 72 hours
Cells were attached to the modified surface (Magnification: x 200) but the adhesion was
not satisfied in comparison to Figure 3a & b.
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Figure 3.4 Cells attached on method II modified surface at 72 hours
Cell adhesion was nice hours (Magnification: x 200) and similar to method I (GA:
0.08%) modified silicone rubber (Figure 3.3a).

Figure 3.5 Cells attached on silicone rubber surface at 72 hours
Few cells were attached on silicone rubber and other cells were floating in the media
(Magnification: x 200).

3.1.2 Coating a Biocompatible Nanofilm on Silicone Rubber
3.1.2.1

Contact Angle Measurements. Contact angle measurements were made for

the PEI/PSS multilayers. The mean contact angles on PEI and PSS surfaces were 76° and
83° respectively. The contact angle measured on the silicone rubber surface was 108°.
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Figure 3.6 Contact angle measurements vs adsorption layers

Nanofilms coated on silicone rubber substrate with the outermost layer o f poly-Dlysine, gelatin, collagen, fibronectin, laminin, hyaluronic acid, or heparin are hydrophilic
(Ai, 2002e). Here, contact angle changes with the film composition o f (PEI/PSS )2 +
(PEI/Gelatin ) 5 are shown in Figure 3.6. Every polymer layer was characterized by a
unique contact angle. Unmodified silicone was hydrophobic with a contact angle o f 107°.
The mean contact angles on PEI and PSS are similar to those in Figure 3.5 The averaged
contact angle o f the gelatin layer was about 55°, which indicated a significantly
hydrophilic surface in comparison to unmodified silicone rubber.
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Figure 3.7 Contact angle measurements during the coating procedure

3.1.2.2

Nanofilm Thickness. Film growth on PDMS was indirectly estimated

through coating multilayers on quartz crystal microbalance (QCM) electrodes. QCM
frequency shifts were proportional to the amount o f mass adsorbed on the electrodes. The
thickness o f a single layer ranged from 0.5 nm to 4 nm. The added mass and the coating
thickness (AL) can be calculated from the frequency shift (AF) according to the
Sauerbrey equation combined with a special scaling (Sauerbrey, 1959; Lvov, 1995). For
the instrument used in this study, the calibration is AL (nm) = 0.017 AF (Hz).
The frequency shift vs adsorption layers o f (PEI/PSS)6 is shown in Figure 3.7.
The film thickness was about 30 nm. Linear film thickness growth was noticed with the
number o f layers increased. The averaged layer thickness o f PEI was 2.4 nm, similar to a
PSS layer.
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Figure 3.8 (PEI/PSS>6 film growth vs frequency shift

The film with the composition o f (PEI/PSS )3 + (PEI/gelatin )5 thickness vs the
adsorption layer is shown in Figure 3.8. The precursor layer o f (PEI/PSS^ was first
adsorbed on the QCM electrode with a frequency shift o f 460 Hz corresponding to a
thickness o f 14.5 nm. The first gelatin layer has a thickness o f 1.5 nm. But the following
PSS layer has a negative frequency shift of 20 Hz. Every gelatin layer was adsorbed on
the electrode alternatively with a polycation layer of PEI. A PEI layer with a negative
frequency shift indicating a previous adsorbed gelatin layer was partially removed by the
strongly charged polycation PEI. Here, every PEI layer has a negative frequency
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following a gelatin layer. The averaged frequency shift o f a PEI layer was -25 Hz. A
total o f five gelatin layers were adsorbed and the averaged layer thickness was o f 1.4 nm.
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Figure 3.9 PEI/gelatin film thickness vs adsorption layers

Multilayers o f PDL/gelatin were assembled on the QCM electrode (Figure. 3.9).
Here, a positively charged polypeptide PDL was used instead o f the polycation PEI in
film formation. The averaged gelatin layer thickness was 2 nm compared with 1.4 nm
formed in (PEI/gelatin) multilayers. No gelatin layer removal was observed in the
assembling process. The alternative adsorption with PDL resulted in linear film growth
vs adsorption layers. The thickness o f the PDL layer increased as more layers were
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coated. The averaged layer thickness o f PDL was 2.2 nm. Thus, PDL/gelatin multilayers
with predictable gelatin layer thickness could be built and no partial removal.
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Figure 3.10 PDL/gelatin film frequency shift/thickness vs adsorption layers
3.1.2.3 Endothelial Cell Adhesion and Growth on Gelatin Nanofilm. In addition
to seeding endothelial cells on the gelatin nanofilms, other cells such as nerves cells,
smooth muscles, and hepatocytes were successfully seeded on polypeptide nanofilms (Ai,
2002e).
PEI/PSS multilayers with different outermost layers were tested for cell adhesion
and growth. Cells could not adhere on the (PSS/PEI)6 film with the PEI as the outermost
layer three days after seeding. In contrast, most cells attached onto the film composed o f
(PSS/PEI) 5 + PSS with the outermost layer o f PSS. The reason was not clear; it may rely
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on a higher cytotoxicity caused by polycation PEL Or the surface charge o f endothelial
cells may have been positive which helped cell adhesion on negatively charged PSS
layer. However, even the film with PSS as the outermost layer could not maintain the
cells for more than one week. Neither o f these polyion layers was biocompatible for cell
adhesion and growth. In another experiment, a polyion film with the outermost layer of
PDDA was tested, but no cell adhesion was observed after 3 days of seeding.
The film o f (PSS/PEI) 3 + PSS + (PEI/gelatin)s was also coated on a silicone
rubber substrate for cell adhesion and growth. Most cells were well adhered on the film
after 24 hours o f seeding, and cell adhesion remained stable 2 weeks after seeding.
Finally, the film with the polypeptide layers (PDL/gelatin )5 was deposited on
silicone rubber for cell adhesion and growth test. Endothelial cell attachment and growth
were observed at 4 hours, 24 hours, 72 hours, one week, and one month after seeding.
The initial seeding density was 1.13 x 105 cells/cm2. After one week o f seeding, the cell
density reached to 1.35 x 105 cells/cm2. As mentioned before, no cell adhesion was found
on an unmodified silicone rubber substrate after 3 days of seeding.
Partial cell adhesion to the PDL/Gelatin nano film was observed after 4 hours of
seeding. At 24 hours, cells were well attached on PDL/gelatin multilayers. Cells labeled
with Cell Tracker (Molecular Probes) continued to grow on the modified silicone rubber
substrate one week after seeding (Figure 3.11). Endothelial cells were well attached on
the nanofilms even after one month.
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Figure 3.11 Bovine coronary artery endothelial cells attached on a (PEI/PSS)? +
(PDL/geIatin)5 nanofilm

3.2 Nano-Encapsulation of Platelets
3.2.1 Nano-Encapsulation of Fixed Platelets
3.2.1.1

Elaboration o f the Polvion / Nanoparticle / Immunoglobulin Assembly on

a Plane Surface. For routes (A) and (B), the film thickness is shown for each adsorption
cycle in Figure 12 (A). Film thickness was calculated from QCM frequency shifts. A film
thickness o f polyions varied with ionic strength o f the solutions. It was reasonable to
have a 2-nm bilayer thickness for PDDA/PSS deposited at 0.137 M NaCl in PBS.
Assembly steps for 78-nm silica or 45-nm FN nanoparticles were easily detected because
the film thickness sharply increased. The increases in measured thickness were close to
the diameters o f nanoparticles used.
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Figure 3.12 Film thickness of each assembly layer for
(PDDA/PSS)(PDDA/Silica)2/PDDA and (PDDA/PSS)(PDDA/FN):>/PDDA
The first three layers are 5 to 7 nm thick. The (PDDA/Silica) layers are 78 to 82 nm thick,
corresponding to the diameter o f the silica particles. The (PDDA/FN) layers are 36-40 nm
thick, corresponding again to particle diameter.

Assembly o f (PSS/IgG)s and (PSS/anti-IgG)s multilayers are shown in Figure.
13(B). Each point represents an IgG or anti-IgG adsorption layer. The pre-layer sequence
was PDDA/PSS/PDDA, and additional layers o f (PSS/IgG)s or (PSS/anti-IgG )5 were
added later. The averaged frequency shift o f every IgG layer was 89 Hz. As calculated,
IgG adsorption density during 30 min on QCM electrodes was 3.7 mg/m2. To
demonstrate the specific binding ability o f assembled IgG, the resonator (with outermost
IgG) was dipped in a solution o f anti-IgG-FITC for 30 min. The bound anti-IgG-FITC
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layer coverage was 5.6 mg/m2. Thus, IgG in the multilayer is specifically recognized by
anti-IgG. On another electrode, multilayers o f (PSS/anti-IgG)s were assembled. The
outermost anti IgG layer remained biologically active. The adsorption density o f the
bound IgG layer is 7.2 mg/m2, almost twice the thickness o f 3.7 mg/m2 found for the
(PSS/IgG ) 5 layers. Thus, more IgG was absorbed onto anti-IgG than IgG bound to PSS
layer. The biological specific binding between antigens and antibodies thus appears to be
stronger than electrostatic binding.
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Figure 3.13 Adsorption density of each assembly layer for IgG and anti IgG coatings
For (PSS/IgGVanti IgG, every IgG layer has an average density o f 3.7 mg/m , and the
final anti IgG layer has a density o f 5.6 mg/m2 and the final IgG layer has a density o f 7.2
mg/m2.
Usually the isoelectric point (PI) of IgG was near pH 7. The exact PI value of
bovine IgG was not known here. The charge o f IgG could be weakly negative or positive
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at pH 7.4. Whereas the procedure is not limited to polyanion PSS, polycation PDDA was
used to assemble IgG in a separate experiment. The averaged film thickness of each IgG
layer was about 2.1 mg/m2 (Figure 3.14). It was much smaller than the value o f 3.7
mg/m2 for IgG adsorbed on PSS layers. The reason is not clear. Assembly of IgG was at
pH 7.4, which is slightly higher than its isoelectric point (Caruso, 1997). The orientation
o f IgG molecules on the film surface is not definite. An upright position would be helpful
for binding o f anti-IgG.
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Figure 3.14 Assembly procedure of (PDDA/IgG)s + Anti-IgG
Adsorption density o f each assembly layer for IgG and anti IgG coatings was shown in
the assembly with PDDA. The averaged IgG adsorption density is 2.1 mg/m2. The final
adsorbed anti-IgG layer has a density of 2.75 mg/m2.
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3.2.1.2

Assembly o f Polvion / Nanoparticle / Antibody Coating on Platelets.

Transmission electron microscopy (TEM, Philips CM 10) and fluorescence microscopy
(Nikon) were used to examine the results o f silica nanoparticle and FN shell assembly on
platelets respectively. A bovine platelet in the initial non-treated state is shown in Figure
3.15a the diameter o f the platelet is 2.5 pm. In Figure 3.15b, four platelets coated with
silica shells are presented. One o f them (arrow) is presented in Figure 3.15c at higher
magnification. The platelet (not the same one from Figure 3.15a is covered with silica
nanoparticles. The size o f the platelet was retained after the silica encapsulation, but its
shape was slightly disturbed.

*1 micron
Figure 3.15a. A bovine platelet (TEM image x 21K)
The platelet is intact (not a cross sectional view). The inner components could not be
clearly viewed. The platelet membrane is clearly presented.
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*
4 micron

Figure 3.15b. Four platelets coated with 78 nm silica shell with composition
PDDA/PSS/PDDA+(SiIica/PDDD)2 (TEM x 1.65K)

1

1 m icr o n

Figure 3.15c. A magnified image of a platelet (arrow) from (b) (TEM x 21K)
The platelet (D=2.8 pm) is totally covered with 78-nm silica. The size o f the platelet in
(c) is close to that of the platelet in (a).

In another experiment, platelets were covered with fluorescent nanospheres
following the construction plan PDDA/PSS/PDDA+(FN/PDDA) 2 ,

Figure. 3.16 (a).

These platelets have a yellow-green color under a fluorescence microscope due to FN
coverage o f the platelet surface, indicating full surface coverage with FN-nanoparticles.
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6 micron

Figure 3.16a Platelets coated with 45 nm fluorescence nanospheres
(Magnification: IK) Both single platelet and clumped platelets were seen in the same
field. Platelets were yellow-green in color and membranes were clearly seen.

Figure. 3.16b shows platelets assembled with an outermost layer o f (PSS/IgGh
that were exposed to a solution o f fluorescent anti-IgG-FITC. Before the antigenantibody recognition, platelets were invisible under the fluorescent microscope, but after
the specific recognition reaction the platelet membrane became visible. Thus, the IgG
assembled on the platelet surface was specifically recognized and bound by anti-IgGFITC, and immunoglobulin-covered platelets can be targeted to specific sites based on
this interaction.

4 micron
Figure 3.16b Platelets assembled with bovine IgG and labeled with anti-bovine IgGFITC
(Magnification: 1.8K). Platelets were clearly viewed due to fluorescent FITC.
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Next, bovine IgG was deposited through LbL self-assembly at a specific area in
the silicone tubing, and the other parts o f the tube remained uncovered with IgG. One
tenth o f the length (8 mm) o f protein-deposition-resistant silicone medical tubing was
selectively coated with bovine IgG on the inner surface. A solution o f platelets shelled
with anti-bovine IgG-FITC was then passed through the tubing 20 times. Afterwards, the
tubing was rinsed, dried, and studied under a fluorescence microscope. Results are shown
in Figure 3.17. The samples were taken from targeted (A) and non-targeted (B) areas.
After analysis with MatLab image processing software, the fluorescence signal from the
targeted areas was 154-times larger than that from non-targeted areas, indicating binding
o f platelets predominantly to the IgG labeled site. This experiment demonstrates the
ability to target antibody-modified platelets to specific sites (expressing related antigens)
in blood vessel.
N o n - T a r g e t e c l A re a

T a r g e t e d A rea

i

200 m icro n

Anti-bovine IgG-FITC
encapsulated platelets

2 0 0 m ic ro n

I

Bovine IgG coated area

Figure 3.17Anti-IgG shelled platelets targeted to an area based on anti-IgG-FITC
recognition of IgG covered regions
Most o f the IgG area was bound by modified platelets, and the fluorescence signal was
obvious.
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3.2.2 Nano-Encapsulation of Live Platelets
Live platelets were coated with polyelectrolytes o f (PDDA/Heparin). Most cells
were still alive after coating as determined from the labeling with Live/Dead Cytotoxicity
Dye.
3.2.2.1

Elaboration o f the Polyion / Heparin Assembly on the Plane Surface. To

understand the PDDA/heparin assembly on live platelets, the adsorption steps were
performed on QCM electrodes. The frequency shift vs adsorption layers were shown in
Figure. 3.18. The film was composed o f (PDDA/PSS ) 2 + (PDDA/heparin)7 . The
polysaccharide heparin was negatively charged and deposited alternatively with
polycation PDDA. The heparin layer thickness increased with the number o f layers
assembled on the electrode. The averaged heparin layer thickness was 3 nm. No removal
phenomenon o f heparin was observed after the adsorption o f strongly charged
polycations PDDA.
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Figure 3.18 Frequency shift/film thickness vs adsorption layers of PDDA/heparin
multilayers
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The live platelets coated with (PDDA/heparin) were immediately labeled with the
Live/Dead cell viability/cytotoxicity sensor. Live cells were green under the fluorescence
microscope while dead or damaged cells were red. In our study, most platelets were
green, as shown in Figure 3.19 and Figure 3.20. Initially, under the microscope, platelets
were oval or round in shape (Figure 3.19). After 30 minutes, platelets changed from the
normal disc shape to a compact sphere with long dendritic extensions (Figure. 3.20). Oval
or round shaped platelets are likely to be in the resting state (inactivated), but plateletes
with long dendritic extensions are likely to be activated. This results indicated that
platelets

were

not

inactivated

after encapsulated

with polycation

PDDA

and

polysaccharide heparin. Also, platelets were still responsive to external forces caused by
the oil lens during the microscopy study. This means platelet function was preserved after
encapsulation.

Figure 3.19 Platelets after encapsulation and labeled with LIVE/DEAD cell
viability/cytotoxicity sensor under fluorescence microscope at 0 min
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Figure 3.20 Platelets after encapsulation under fluorescence microscope at 30 min

Live/Dead cell viability/cytotoxicity sensor-labeled platelets were also studied
with the aid of a fluorometer. Live and dead cells gave off fluorescence emissions at
different wavelengths. In Figure 3.21, live platelets were excited at 494 nm and emitted
fluorescence signal at 517 nm.
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Figure 3.21 Live/dead platelet emission at different wavelengths
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Dead platelets emitted fluorescence at 617 nm when excited at 528 nm (Figure.
3.22). The fluorescence intensity o f live and dead platelets is summarized in Figure. 3.23.
Live platelets have much stronger fluorescence intensity as compared with dead/damaged
platelets. The emission fluorescence intensity o f live platelets was about 3.2 x 106, while
that o f dead platelets was 2271. The cell number ratio o f live: dead cells is equal to 1409:
1. This result indicates that most cells (99.93%) were alive and the encapsulation was
non-cytotoxic.
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Figure 3.22 Fluorescence signal of dead platelets at 617 nm when excited at 528 nm
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Figure 3.23 fluorescence intensity of live and dead platelets

3.3 Thromboxane B-> Measurement through ELISA
The amount o f thromboxane B2 (TXB 2 ) released from uncoated and encapsulated
platelets after flow through the endothelium-lined model was measured through ELISA.
TXB 2 was calibrated from 0.5 to 64 pg with concentration varying from 7.7 * IO-4 to 9.8
x 10'2 pg/pl (Figure. 3.24). Sample concentration was estimated from the standard curve.
The averaged TXB 2 level released from shelled platelets was 1.17 ± 0.22 ng/ml compared
with 1.60 ± 0.09 ng/ml from non-shelled platelets (Figure. 3.25). After encapsulation,
TXB 2 release from platelets was significantly decreased (p<0.01).
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Figure 3.25 The level of TXB 2 released from shelled and non-shelled platelets

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

91

3.4 Platelet Adhesion Test in the Stenosis Model
The number o f platelets before and after running through the collagen-coated
silicone model was measured by fluorescence intensity counting. The fluorescence
absorbance o f Calcein used here was 517 nm (emission) for live platelets. The
fluorescence absorbance of shelled and non-shelled platelets before and after running the
model was recorded. Two groups were set for the experiment, the shelled platelets and
the non-shelled platelets. Five samples were in each group, and data were paired. After
running through the model, some platelets were adsorbed onto the coated collagen film
on the inner surface of the silicone model, so the fluorescence intensity o f platelets after
running through the model was lower than the intensity before running the model. The
difference o f platelet fluorescence intensity divided by the intensity before running yields
the percentage o f platelet adhesion onto the collagen nanofilm. An example o f the
fluorescence intensity change o f non-shelled platelets before and after running through
the model is shown in Figure 3.26.
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Figure 3.26 The fluorescence intensity of non-shelled platelets
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PDDA/heparin encapsulated platelets showed less adhesion on collagen as
compared with unmodified platelets (p<0.01) (Figure. 3.27). Only 3.84% o f shelled
platelets were attached to the collagen film after running the fluid through the silicone
model, whereas 36.84% o f unmodified platelets were attached. Thus, PDDA/heparin
encapsulation on platelets reduced the degree o f platelet adhesion on collagen in the
coronary artery stenosis model.
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Figure 3.27 Percentage of shelled and non-shelled platelets adhesion to the collagen
nanofilm

3.5 Nitric Oxide Release from the Endothelial Cells
A Nitric Oxide Fluorescence sensor was used to quantify the amount o f NO
release from the endothelial cells. Endothelial cells were collected from different parts o f
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the model for flow cytometry analysis. But the fluorescence sensor was not sensitive
enough to measure the amount the nitric oxide released from endothelial cells under the
flow condition (Re = 436). The negative control from cells without fluorescence labeling
has a background signal o f 2.94 (Figure. 3.28). The fluorescence intensity was 2.35, 2.12,
2.17, and 2.08 for region 1, 2, 3 and 4 respectively (Figure. 3.29). In Figure 3.29, the
fluorescence intensity o f NO was counted from region M l. Based on the amount o f cells
per region, the fluorescence intensity is replotted as shown in Figure. 3.30.
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FL1-H
Figure 3.28 Fluorescence intensity of cells without DAF-FM diacetate labeling
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Figure 3.29a Fluorescence intensity of NO release at region 1
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Figure 3.29b Fluorescence intensity of NO release at region 2
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Figure 3.29c Fluorescence intensity o f NO release at region 3
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Figure 3.29d Fluorescence intensity o f NO release at region 4
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Figure 3.30 Fluorescence intensity of NO release at all regions
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CHAPTER 4

DISCUSSION

4.1 Introduction
Polyion shells were assembled on the platelets to modify their functions under the
high shear stress conditions caused by the stenosis. A coronary artery stenosis silicone
model was built for nano-engineered platelet function analysis in this study. To simulate
the physiological environment of a blood vessel, endothelial cells were seeded on the
inner surface o f the model. A micro/nano biocompatible film was coated on the inner
surface o f silicone model through layer-by-layer self-assembly. A poly-D-Iysine/gelatin
nanofilm was used to increase endothelial cell adhesion. Collagen coating on the inner
surface o f the model was used for platelet adhesion study. The architecture of a nanofilm
is pre-determined and the thickness is predictable.
Encapsulation o f platelets with polyions, nanoparticles, and antibodies brought a
new method for cell surface modification. The coating was successful for both fixed and
live platelets. Live platelets were still alive and functional after encapsulation. Polyions
such as PDDA did not show obvious cytotoxicity to cells. The interaction between cells
and coating materials was based on the electrostatic force in all polyions, except for the
antibodies which relied on hydrophobic forces. Activation under shear stress was reduced
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for the encapsulated platelets, as determined from the thromboxane B2 measurement.
Adhesion o f shelled platelets to the collagen film was obviously lower than adhesion o f
unmodified platelets. Thus, a platelet’s function can be changed by the nano-shell.
No obvious nitric oxide release was measured from endothelial cells seeded inside
the model. The possibility may rely on the sensitivity o f the fluorescence sensor or short
time o f flow treatment.
prevented NO production.

Furthermore, a lack o f L-arginine in the fluid may have
Although L-arginine was present in the culture medium

during the culturing of the endothelial cells, the suspended platelet mixture used during
the flow experiment did not have this essential amino acid.

4.2 Micro/Nanofilm Coated on a Silicone Substrate
A gelatin film with a thickness o f 110 ~ 160 pm was coated on silicone rubber
through crosslinking with glutaraldehyde. The film was hydrophilic and biocompatible
for cell adhesion and growth. But glutaraldehyde was required, and it might be cytotoxic
to cells.
Nanofilms o f different architectures were coated on a PDMS substrate with an
outermost layer o f poly-D-lysine, gelatin, collagen, fibronectin, laminin, hyaluronic acid,
or heparin (Ai, 2002e). In our study, PEI/PSS, PEI/gelatin, PSS/collagen or PDL/gelatin
multilayers were assembled on silicone rubber as hydrophilic coatings. Different thin film
monolayers have unique contact angles. An outermost layer dominates the surface
property (Yoo, 1998). A gelatin monolayer has a smaller contact angle compared with a
PEI or a PSS monolayer. So it is desired to use an outermost layer of gelatin in coating
nanofilms on a silicone rubber substrate to increase the hydrophilicity.
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PEI/PSS, and PDL/gelatin multilayers demonstrated linear film thickness growth
in QCM studies. But a gelatin layer removal phenomenon was observed in constructing a
film composed o f PEI/gelatin multilayers. The reason is unclear. It is possible that the
weakly charged gelatin layer was peeled off by strongly charge polycation PEI. After
replacing PEI with the weakly charged polypeptide PDL, a linear PDL/gelatin film
growth was observed. PEI/PSS multilayers also presented linear film growth without the
removal phenomenon, but cells adhered to the film for only one week. A PDL/gelatin
film is thus preferable for its biocompatibility. The thickness o f a PDL/gelatin bilayer is
about 4 nm and the total film thickness is pre-determined.
Endothelial cells adhered to hydrophilic films coated on a silicone rubber
substrate. However, the film composed o f a PEI/PSS multilayer was not stable enough to
hold cells for more than one week. Cells could not adhere on the (PSS/PEI)6 film with the
outermost layer o f PEI three days after seeding. Endothelial cells adhered on the film
composed o f (PSS/PEI)s + PSS with an outermost layer o f PSS. A PEI layer might be
cytotoxic to cells, or else the negative charge o f the PSS layer was good for cell adhesion.
Nonetheless, even the film with PSS as the outermost layer could not hold cells for more
than one week. Neither a PEI nor a PSS layer was biocompatible for cell adhesion and
growth. In another experiment, a polyion film with the outermost layer of PDDA was
also tested but no cell adhesion was observed 3 days after seeding. Cell adhesion and
growth were observed on PEI/gelatin, and PDL/gelatin multilayers up to one month. Cellfilm interactions were monitored by using a Cell-Tracker fluorescence sensor. Most cells
were alive on the nanofilms and no obvious cytotoxicity was observed. A PDL/gelatin
film was used instead o f a PEI/gelatin film coating on the inner surface of the silicone
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model o f coronary artery stenosis. Poly-D-lysine is a widely used biomaterial in cell
culture, but the biocompatibility o f PEI was not thoroughly understood even though it has
been used in gene delivery (Baker, 1997; Gautam, 2000).

4.3 Nano-Encapsulation of Platelets
4.3.1 Nano-Encapsulation of Fixed Platelets
Fixed platelets were successfully coated with different materials. A precursor film
o f PDDA/PSS multilayers is preferred as a strong substrate for further adsorption o f
nanoparticles or proteins. In another experiment, polycation PEI was used to build the
precursor film alternatively with PSS, but platelet aggregation was found. The reason
may be a reaction o f the positively charged NH 2+ group o f PSS with the negatively
charged COOH' group o f glycoproteins on platelets. A similar aggregation phenomenon
was also found in encapsulation o f fiirosemide microcrystals with PEI (Ai, 2002b). The
shell thickness could be adjusted by varying the ionic strength o f the coating solution. It
was reasonable to have a 2-nm bilayer thickness for PDDA/PSS deposited in 0.137 M
NaCl solution (Lvov, 1995). Assembly of negatively 78-nm silica or 45-nm fluorescence
nanoparticles with positively charged PDDA was observed with the help o f TEM and
fluorescence microscopy respectively. Usually the addition o f an outermost layer of
strongly charged polyelectrolyte was preferred to prevent loss o f nanoparticles from
platelets. Here, a PDDA layer was used as the final treatment.
A layer o f IgG adsorption density on QCM electrodes was 3.7 mg/m2, which is
similar to a previous study (Caruso, 1997). IgG adsorbed on the electrode was still
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bioactive to bind an anti-IgG-FITC layer with a coverage of 5.6 mg/m2. Greater IgG
adsorption was found on electrodes when assembling with polyanion PSS than polycation
PDDA. Assembly o f IgG was at pH 7.4, slightly higher than its isoelectric point (Caruso,
1997; Buijs, 1995). Thus, the protein surface was approximately neutral in charge, and
some additional interaction facilitated the stronger interaction of IgG with anionic PSS
rather than with cationic PDDA. Probably, hydrophobic forces between PSS and IgG
play an important role (Caruso, 1997). Also PSS may exhibit more roughness than
PDDA, which may improve IgG adherence. The orientation of IgG molecules on the film
surface is not definite. An upright position would be helpful for binding o f anti-IgG.
IgG assembled on the platelet surface was specifically recognized and bound by
anti-IgG-FITC, and vice versa. Therefore, most antibodies demonstrated the bio-specific
binding ability even in a flow condition. This result may bring possible applications in
drug delivery and targeting in treating tumors.

4.3.2 Nano-Encapsulation of Live Platelets
Live platelets were coated with polycation PDDA and polysaccharide heparin.
The total time o f the assembly procedure was kept short to ensure platelet viability and
function after the encapsulation. From a Live/Dead Cell Viability/Cytotoxicity test, most
cells were alive and not damaged by the PDDA/heparin shell. Heparin was chosen for the
assembly procedure because o f other major anticoagulant materials, such as citric acid,
have small molecular weights that preclude LbL assembly. Heparin is a negatively
charged polysaccharide (PI: 9.5) at pH 7.4. In contrast to the encapsulation procedure for
fixed platelets, fewer layers were used in assembly. One important reason is that the
biocompatibility and cytotoxicity o f PDDA is unknown. A biocompatible polyion,
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strongly positively charged, that does not cause platelet activation, is preferable for
assembling multilayers on platelets with heparin.

4.4 Thromboxane B-> Release from Platelets
The Poiseuille value for shear stress at the throat o f the stenosis in the silicone
model is 23 dynes/cm2. This is a lower estimate because the start o f the stenosis is a
contracting flow the true shear stress will be substantially higher. Shear stress higher
than 50 dynes/cm2 can lead to platelet activation and aggregation (Huang, 1993).
Encapsulation o f platelets with the nanofilm may modify platelet a granule and dense
granule release upon shear stress activation.
Thromboxane B2 is an important indicator for platelet activation and aggregation.
Here, TXB 2 released from platelets was measured through ELISA. All samples were
prepared from pure platelets instead o f platelet rich plasma (PRP). Encapsulated platelets
released significantly less TXB 2 (1.60 ± 0.09 ng/ml) than did unmodified platelets (1.17 ±
0.22 ng/ml) (p<0.01). The reason is unclear. High shear stress could cause a special
platelet quick-release reaction called granule-membrane-fused lytic release (GFLR)
(Song, 1990). It is possible that the heparin on the outermost layer limited shear-induced
platelet secretion, thus reducing the amount o f platelet recruitment. From previous
studies, platelets release much more TXB 2 in the presence o f ECM (Eldor, 1989). Also,
the encapsulated shell on a platelet might limit TXB 2 release and lead to a lower TXB 2
concentration. The amount o f TXB 2 release in PRP due to matrix-platelet interaction was
much higher than the release in these studies (32.4 ng/ml) (Eldor, 1989).
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4.5 Platelet Adhesion
The interaction o f platelets with collagens o f the vessel wall is a critical event in
primary hemostasis. Collagen-platelet interaction is a two-step process o f adhesion and
activation involving the sequential recognition o f distinct receptors. Adhesion involves
first the reversible recognition o f collagen-bound vWF by the platelet receptor complex
GP Ib/IX/V, followed by direct interaction between collagen and the platelet integrin
receptor (X2 P 1 (Bames, 1998). In our study, collagen type I was used in assembly of
multilayers in film coating on the inner surface o f the silicone model. Collagen fibrils and
immobilized collagen could bind strongly to platelets (Moroi et al., 1997). Collagen type
I can induce a-granule secretion and up-regulation of cell surface GPIIb-IIIa (Alberio et
al., 1998). Platelet adhesion and aggregation on collagen VI are different in shear rate
dependence from collagen I (Ross et al., 1995b). Chiang et al. (1993) suggested that type
I collagen and type III collagen interact with platelets at separate sites.
It has been shown that heparin, by inhibiting the thrombin-GPIb interaction, is
able to interfere with thrombin-induced platelet activation (De Candia, 1999). An
increased surface expression o f GPIIb-IIIa stimulated by HSS has been found from a
previous study (Song, 1990). Heparin coating on the cardiopulmonary bypass oxygenator
membrane can reduce platelet adhesion and activation (Niimi, 1999). Here, heparin
coating on platelets may function as a shield to prevent external force activation and
reduce platelet surface glycoprotein expression. After going through the high shear stress
site at the stenosis, platelets were activated and “sticky.” In our study, much less
encapsulated platelet adhesion on collagen was observed compared with unmodified
platelets. The outermost layer heparin blocked platelet surface glycoprotein binding to
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collagen nanofilm to a high degree. The encapsulation provided a protective shell to
prevent platelet adhesion on collagen under high shear stress. So only 3.84%
encapsulated platelets adhered to the collagen substrate compared with a much higher
binding rate o f 36.84% for unmodified platelets. Still, 3.84% platelets were adhered on
collagen substrate and this adhesion is possibly due to the binding effect between
collagen and heparin (Keller, 1986).

4.6 Measuring Nitric Oxide Release from Endothelial Cells
No nitric oxide release signal was detected from DAF-FM diacetate labeling in
our study. The basal level o f NO release from 105 endothelial cells was in the range o f
140 —504 pmol (Guo, 1996). The theoretical detection limit of DAF-FM diacetate was
about 3 nM (Kojima, 1999). A fluorescence intensity o f 2200 corresponded to a NO
concentration o f 1.2 pM (Kojima, 1999). In his study, endothelial cells incubated with
DAF-FM diacetate did not give off a fluorescence signal without bradykinin stimulation.
On the contrary, an electrochemical sensor was sufficiently sensitive to detect the basal
NO release from endothelial cells (Guo, 1996). It is possible that the dye may not be
sensitive enough to detect normal NO release from endothelial cells. In our study, the
flow treatment might be too short (< 1 hour) to cause large amount o f NO release from
endothelial cells. The small amount o f NO release as well as the low sensitivity o f dye
led to the failure o f NO detection.
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CHAPTER 5

CONCLUSIONS AND RECOMMENDATIONS

5.1 Conclusions
5.1.1 Micro/Nano-Film Coating
Two gelatin glutaraldehyde (GA) crosslinking methods have been used to coat a
hydrophilic membrane with micrometer thickness o f silicone rubber in this study. In
method I, gelatin and GA were mixed in three different proportions (64:1, 128:1 and
256:1) before coating. In method II, a newly formed 5% gelatin membrane was
crosslinked with a 2.5% GA solution. All coatings were hydrophilic, as determined from
the measurement o f contact angle for a drop of water on the surface. Bovine coronary
arterial endothelial cells (BCAEC) grew well on the surface modified by method II at 72
hours. In method I, the cells grew well for gelatin:GA proportions o f 64:1 and 128:1 at
72 hours. No cell attachment on untreated silicone rubber was observed by the third day
o f seeding. The results indicated that both methods o f gelatin GA crosslinking provided a
hydrophilic surface on silicone for endothelial cell adhesion and growth in vitro.
Nanofilms o f different compositions have been successfully coated on silicone
rubber through the electrostatic LbL self-assembly technique. The technique was
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successful not only on the planar sufaces in the Petri dishes, but also on the curved
surface inside the coronary artery stenosis models. The films were hydrophilic, as
determined from contact angle measurements. The film composed o f PDL/gelatin
multilayers was biocompatible for endothelial cell adhesion and growth.

5.1.2 Nano-Encapsulation o f Platelets
Nanoparticles and immunoglobulins were assembled in nano-organized shells on
bovine platelets through an electrostatic LbL self-assembly technique. Platelets were the
second class o f blood cells modified with nano-assembly after erythrocytes (Mohwald,
2000). The coverage o f 78-nm silica and 45-nm fluorescent nanospheres on platelets was
studied under TEM or fluorescence microscopes. An IgG-layer was adsorbed on platelets
in alternation with poly(styrenesulfonate), and its specific immune-recognition and
targeting with fluorescent anti-IgG-FITC were demonstrated. The technique makes
several platelet modifications possible. First, abnormal receptor-agonist interactions
could be blocked by nano-shells. Second, platelet aggregation could be altered due to
novel surface properties o f the cells. Third, platelet secretion could be controlled by
thickness and composition o f the nano-shell. Fourth, platelets can be targeted to specific
sites in a blood vessel through antibody coating. These results show that it is possible to
modify biological cells properties by assembling different materials. The presented
approach o f organized nano-shell formation can be extended to other cells or microbes
for their surface modification or encapsulation.
The method is not limited to fixed platelets. Live platelets were also coated with
polyions with a outermost layer o f heparin. Most platelets were alive after the coating
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procedure and no obvious cytotoxicity was observed. Also, platelets were not activated
after encapsulation. Under high shear stress generated by the stenosis in the silicone
model, encapsulated platelets released less TXB 2 compared with unmodified platelets.
Platelets with a heparin coating did not readily adhere to the collage substrate. The
heparin shell might block the possible binding reactions between collagen and platelet
surface glycoproteins. So the nano-engineered platelets reduced shear stress induced
activation and adhesion.

5.2 Recommendations
It would be desirable to investigate and understand the detailed shell function
during platelet activation and adhesion. Therefore, measuring platelet secretion of
serotonin, von Willebrand factor, nitric oxide, ADP and other key materials are
interesting and important for future study* In addition to the collagen substrate used here
to study platelet adhesion, coatings o f fibrinogen or vWF would be useful in studies
designed to examine the mechanism by which the shell blocks the interaction between
platelets and related ligands.
Shells with different compositions and outermost layers could also be applied
onto platelets. The architecture o f a shell is dependent on the application. One important
procedure is to coat specific antibodies on platelets for tumor targeting.
The geometry o f the stenosis or the Reynolds number can be varied for studying
platelet reactions under different flow conditions.
Finally, it would be o f great use to see how modified platelets interact with other
blood components such as red blood cells. This observation may be accomplished by
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adding encapsulated platelets into whole blood and measuring related parameters. Both in
vitro and in vivo models could be used for these studies.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

REFERENCES

Aarts, P. A., van den Broek, S. A., Prins, G. W., Kuiken, G. D., Sixma, J. J., and
Heethaar, R. M., Blood platelets are concentrated near the wall and red blood cells, in the
center in flowing blood, Arteriosclerosis, 8, 819 (1988).
Abbate, R., Marcucci, R., Camacho-Vanegas, O., Pepe, G., Gori, A. M., Capanni, M.,
Simonetti, L, Prisco, D., and Gensini, G. F., Role o f platelet glycoprotein PL(A1/A2)
polymorphism in restenosis after percutaneous transluminal coronary angioplasty,
American Journal o f Cardiology, 82, 524 (1998).
Abrams, C. S., Ellison, N., Budzynski, A. Z., and Shattil, S. J., Direct detection o f
activated platelets and platelet-derived microparticles in humans, Blood, 75, 128 (1990).
Abrams, C., and Shattil, S. J., Immunological detection o f activated platelets in clinical
disorders, Thrombosis and Haemostasis, 65, 467 (1991).
Ai, H., M. Fang, Y. M. Lvov, D. K. Mills, and S. A. Jones, “Electrostatic layer-by-layer
self-assembly on biological micro/nanotemplates: platelets and tobacco mosaic vims”,
Louisiana 2nd MEMS conference, 2001a.
Ai, H., M. Fang, S. A. Jones, Y. M. Lvov, “Electrostatic Layer-by-Layer Nano-Assembly
on Biological Microtemplates: Platelets”, Biomacromolecules, 2002a.
Ai, H., S. A. Jones, M. M. de Villiers, Y. M. Lvov, “Nano-Encapsulation o f Furosemide
Microcrystals for Controlled Drug Release”, JACS, 2002b, submitted.
Ai, H., Mills, D. K., Lvov, Y., Jones, S., “Assembling Biocompatible Nanofilms on
PDMS substrate”, Biomaterials, 2002c, In preparation.
Ai, H., Y. M. Lvov, D. K. Mills, J. S. Alexander, S. A. Jones, “Coating Poly-D-Lysine
Nano-Film on PDMS for Endothelial Cell Adhesion and Growth”, The FASEB Journal,
2002d.
Ai, H., Y. M. Lvov, D. K. Mills, J. S. Alexander, S. A. Jones, “Coating Biocompatible
Nanofilms on PDMS”, BMES 2002 Annual Meeting, October, 2002e.

109
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

110

Ai, H., Y. M. Lvov, D. K. Mills, S. A. Jones, “Micropatteming o f micro/nanospheres on
PDMS by using layer-by-layer self-assembly”, the 2" IEEE-EMBS Microtechnologies in
Medicine and Biology Conference, 2002f.
Ai, H., S. A. Jones, M. M. de Villiers, Y. M. Lvov, “Nano-Encapsulation o f Furosemide
Microcrystals for Controlled Drug Release”, American Chemical Society Annual
Meeting, 2002g.
Ai, H., M. Fang, S. A. Jones, Y. M. Lvov, “Electrostatic Layer-by-Layer Nano-Assembly
on Biological Microtemplates: Platelets”, American Chemical Society Annual Meeting,
2002h.
Ai, H., M. Fang, Y. M. Lvov, D. K. Mills, and S. A. Jones, “Layer-by-Layer NanoAssembly o f Polymers on Silicone Rubber: A New Substrate for Endothelial Cell
Growth”, Society for Biomaterials 28th Annual Meeting, April, 2002.
Albelda, S. M., Muller, W. A., Buck, C. A., and Newman, P. J., Molecular and cellular
properties o f PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule,
Journal o f Cell Biology, 114, 1059 (1991).
Alberio, L. and G. L. Dale (1998). “Flow cytometric analysis o f platelet activation by
different collagen types present in the vessel wall.” British Journal o f Haematology
102(5): 1212-8.
Ambrose, J. A., Tannenbaum, M. A., Alexopoulos, D., Hjemdahl-Monsen, C. E., Leavy,
J., Weiss, M., Borneo, S., Gorlin, R., and Fuster, V., Angiographic progression of
coronary artery disease and the development o f myocardial infarction, Journal o f the
American College o f Cardiology, 12, 56 (1988).
Andrews, N. P., Gralnick, H. R., Merryman, P., Vail, M., and Quyyumi, A. A.,
Mechanisms underlying the morning increase in platelet aggregation: a flow cytometry
study, Journal o f the American College o f Cardiology, 28, 1789 (1996).
Antipov, A.A., G. B. Sukhorukov, G.B., Donath, E., and Mohwald, H., “Sustained
Release Properties o f Polyelectrolyte Multilayer Capsules”, The Journal o f Physical
Chemistry B;, 2001; 105(12); 2281-2284.
Arcidi, J. M., Powelson, S. W., King, S. B., Douglas, J. S., Jones, E. L., Craver, J. M.,
Landolt, C. C., Jackson, E. R., Hatcher, C. R., and Guyton, R. A., Trends in invasive
treatment o f single-vessel and double-vessel coronary disease., Journal o f Thoracic and
Cardiovascular Surgery, 95, 773 (1988).
Ariga, K.; Lvov, Y.; Kunitake, T. Assembling alternate dye-polyion molecular films by
electrostatic layer-by-layer adsorption. J. Am. Chem. Soc., 1997, 119, 2224-2231.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Ill

Ault, K. A. and J. Mitchell (1994). “Analysis o f platelets by flow cytometry.” Methods in
Cell Biology 42 Pt B: 275-94.
Badimon, L., Badimon, J. J., Galvez, A., Chesebro, J. H., and Fuster, V., Influence o f
arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine
model, Arteriosclerosis, 6, 312 (1986).
Badimon, L., B., J. J., Turitto, V. T., Vallabhajosula, S., Fuster. V. (1988). “Platelet
Thrombus Formation on collagen Type I a model o f deep vessel injury influence o f blood
rheology, von Willebrand factor, and blood coagulation.” Circulation 78(6): 1431-1442.
Baker, A., Saltik, M., Lehrmann, H., Killisch, I., Mautner, V., Lamm, G., Christofori, G.,
and Cotten, M., Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for
condensing and linking plasmid DNA to adenovirus for gene delivery., Gene Therapy, 4,
773 (1997).
Bar, F., Vainer, J., Stevenhagen, J., Neven, K., Aalbregt, R., Ophuis, T. O., van Ommen,
V., de Swart, H., de Muinck, E., Dassen, W., and Wellens, H., Ten-year experience with
early angioplasty in 759 patients with acute myocardial infarction, Journal o f the
American College o f Cardiology, 36, 51 (2000).
Baumgartner, H. R., Tschopp, T. B., and Meyer, D., Shear rate dependent inhibition of
platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor
VUI/von Willebrand factor, British Journal of Haematology, 44, 127 (1980).
Belval, T., Heliums, J. D., and Solis, R. T., The kinetics o f platelet aggregation induced
by fluid-shearing stress, Microvascular Research, 28, 279 (1984).
Bennett, J. S., Hoxie, J. A., Leitman, S. F., Vilaire, G., and Cines, D. B., Inhibition of
fibrinogen binding to stimulated human platelets by a monoclonal antibody, Proceedings
o f the National Academy o f Sciences o f the United States o f America, 80, 2417 (1983).
Bennett, J. S., Shattil, S. J., Power, J. W., and Gartner, T. K., Interaction o f fibrinogen
with its platelet receptor. Differential effects o f alpha and gamma chain fibrinogen
peptides on the glycoprotein Ilb-IIIa complex, Journal o f Biological Chemistry, 263,
12948 (1988).
Biotrak. (1994). Thromboxane B2 enzymeimmunoassay (ELA) system. Amersham Life
Science.
Bluestein, D., Niu, L., Schoephoerster, R. T., and Dewanjee, M. K.., Fluid mechanics of
arterial stenosis: relationship to the development o f mural thrombus, Annals of
Biomedical Engineering, 25, 344 (1997).
Bom, G. V. (1970). “Observations on the change in shape o f blood platelets brought
about by adenosine diphosphate.” Journal of Physiology 209(2): 487-511.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

112

Borrione, M., Hall, P., Almagor, Y., Maiello, L., Khlat, B., Finci, L., and Colombo, A.,
Treatment o f simple and complex coronary stenosis using rotational ablation followed by
low pressure balloon angioplasty, Catheterization and Cardiovascular Diagnosis, 30, 131
(1993).
Bottiger, C., Kastrati, A., Koch, W., Mehilli, J., von Beckerath, N., Dirschinger, J.,
Gawaz, M., and Schomig, A., Polymorphism o f platelet glycoprotein lib and risk o f
thrombosis and restenosis after coronary stent placement, American Journal o f
Cardiology, 84, 987 (1999).
Bredt, D. S. and S. H. Snyder (1990). “Isolation o f nitric oxide synthetase, a calmodulinrequiring enzyme.” Proceedings o f the National Academy o f Sciences o f the United
States o f America 87(2): 682-5.
Broekman, M. J., Eiroa, A. M., and Marcus, A. J., Inhibition o f human platelet reactivity
by endothelium-derived relaxing factor from human umbilical vein endothelial cells in
suspension: blockade o f aggregation and secretion by an aspirin-insensitive mechanism,
Blood, 78, 1033 (1991).
Brown, C. H. d., Leverett, L. B., Lewis, C. W., Alfrey, C. P. J., and Heliums, J. D.,
Morphological, biochemical, and functional changes in human platelets subjected to
shear stress, Journal o f Laboratory and Clinical Medicine, 86, 462 (1975).
Bruckdorfer, K. R., Jacobs, M., and Rice_Evans, C., Endothelium-derived relaxing factor
(nitric oxide), lipoprotein oxidation and atherosclerosis., Biochemical Society
Transactions, 18, 1061 (1990).
Brynda, E.; Houska, M. Ordered multilayer assemblies: Albumin / heparin for
biocompatible coating and monoclonal antibodies for optical immunosensors. In book:
Protein Architecture: Interfacial Molecular Assembly and Immobilization Biotechnology,
Ed: Y. Lvov and H. Mohwald, M. Dekker Publ., New York, 2000, 251-286.
Buchwald, A., Werner, G., Unterberg, C., Voth, A., and Wiegand, V., Malignant
restenosis after primary successful excimer laser coronary angioplasty, Clinical
Cardiology, 13, 397 (1990).
Buijs, J.; Lichtenbelt, J. W. Th.; Norde, W.; Lyklema, J. Colloids Surf. B: Biointer.,
1995, 5, 11.
Burlet, S. and R. Cespuglio (1997). “Voltammetric detection o f nitric oxide (NO) in the
rat brain: its variations throughout the sleep-wake cycle.” Neuroscience Letters 226(2):
131-5.
Caruso, F.; Niikura, K.; Furlong, N.; Okahata, Y. Assembly o f alternating polyelectrolyte
and protein multilayer films for immunosensing. Langmuir, 1997, 13, 3427-3433.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

113

Caruso, F.; Caruso, R.; Mohwald, H. Fabrication o f hollow, spherical silica and
composite shells via electrostatic self-assembly o f nanocomposite multilayers on
decomposable colloidal templates. Science, 1998, 282, 1111-1114.
Caruso, F.; Furlong, N.; Ariga, K.; Ichinose, I.; Kunitake, T. Characterization of
polyelectrolyte-protein multilayer films by atomic force microscopy, scanning electron
microscopy and Fourier-transform infrared reflection - absorption spectroscopy.
Langmuir, 1998a, 14, 4559-4565.
Caruso, F.; Mohwald, H. Protein multilayer formation on colloids through a step-wise
self-assembly technique. J. Am. Chem. Soc., 1999, 121, 6039-6045.
Caruso, F.; Trau, D.; Mohwald, H.; Renneberg, R. Encapsulation o f enzyme crystals in
molecularly engineered multilayer capsules. Langmuir, 2000, 16, 1485-1488.
Caspary, E. A., Kekwick, R. A. (1957). “Some physicochemical properties in human
fibrinogen.” Biochem. J. 67: 41.
Cheung, J.; Fou, A.; Rubner, M. Molecular Self-Assembly o f conducting polymers. Thin
Solid Films, 1994, 244, 985-989.
Chiang, T. M., Seyer, J. M., and Kang, A. H., Collagen-platelet interaction: separate
receptor sites for types I and III collagen, Thrombosis Research, 71, 443 (1993).
Chow, T. W., Heliums, J. D., Moake, J. L., and Kroll, M. H., Shear stress-induced von
Willebrand factor binding to platelet glycoprotein lb initiates calcium influx associated
with aggregation, Blood, 80, 113 (1992).
Clark, R. A., Horsburgh, C. R., Hoffman, A. A., Dvorak, H. F., Mosesson, M. W., and
Colvin, R. B., Fibronectin deposition in delayed-type hypersensitivity. Reactions of
normals and a patient with afibrinogenemia, Journal o f Clinical Investigation, 74, 1011
(1984).
Conti, C. R. (1991). “Coronary stenosis after successful angioplasty: clinical observations
[editorial].” Clinical Cardiology 14(11): 863-4.
Cohen, N., Zaidenstein, R., Blatt, A., Sarafian, D. A., Litinsky, I., and Modai, D.,
Unrecognized major bleeding following thrombolysis for acute myocardial infarction
presenting with syncope, Clinical Cardiology, 21, 599 (1998).
Coherent, Inc., Operator’s Manual INNOVA 70C Series Ion Laser, 1997.
Coller, B. S. (1985). “A new murine monoclonal antibody reports an activationdependent change in the conformation and/or microenvironment o f the platelet
glycoprotein Ilb/IIIa complex.” Journal o f Clinical Investigation 76(1): 101-8.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

114

Daniel, J. L., Dangelmaier, C., Strouse, R., and Smith, J. B., Collagen induces normal
signal transduction in platelets deficient in CD36 (platelet glycoprotein IV), Thrombosis
and Haemostasis, 71, 353 (1994).
Dardik, A., Liu, A., and Ballermann, B. J., Chronic in vitro shear stress stimulates
endothelial cell retention on prosthetic vascular grafts and reduces subsequent in vivo
neointimal thickness., Journal o f Vascular Surgery, 29, 157 (1999).
D eC andia, E., De_Cristofaro, R., and Landolfi, R., Thrombin-induced platelet activation
is inhibited by high- and low-molecular-weight heparin., Circulation, 99, 3308 (1999).
de Bono, D. P. and R. S. More (1993). “Prevention and management o f bleeding
complications after thrombolysis.” International Journal o f Cardiology 38(1): 1-6.
Decher, G.; Hong, J-D. Buildup o f ultrathin multilayer films by self-assembly process:
Consecutive adsorption o f anionic and cationic bipolar amphiphiles and polyelectrolytes
on charged surfaces. Ber. Bunsenges. Phys. Chem., 1991, 95, 1430-1434.
Decher, G.; Essler, F.; Hong, J.-D.; Lowack, K.; Schmitt, J.; Lvov, Y. Layer-by-layer
adsorbed films o f polyelectrolytes, proteins or DNA. Polymer Preprints, 1993, 34, 745746.
Decher, G.; Lvov, Y.; Schmitt, J. Proof o f multilayer structural organization o f
polycation/ polyanion self-assembled films. Thin Solid Films, 1994a, 244, 772-777.
Decher, G.; Lehr, B.; Lowack, K.; Lvov, Y.; Schmitt, J. New nanocomposite films for
biosensors: layer-by-layer adsorbed films o f polyelectrolytes, proteins or DNA.
Biosensors and Bioelectronics, 1994b, 9, 677-684.
Decher, G. Fuzzy nanoassemblies: Toward layered polymeric multicomposites. Science,
1997, 227, 1232-1237.
Dewitz, T. S., Martin, R. R., Solis, R. T., Heliums, J. D., and Mclntire, L. V.,
Microaggregate formation in whole blood exposed to shear stress, Microvascular
Research, 16, 263 (1978).
Du, X., Beutler, L., Ruan, C., Castaldi, P. A., and Bemdt, M. C., Glycoprotein lb and
glycoprotein IX are fully complexed in the intact platelet membrane, Blood, 69, 1524
(1987).
Duguid J.B., Thrombosis as a factor in the pathogenesis o f aortic atherosclerosis, J Pathol
B acteriol,, 1985;58:207-212.
Elbert, D.; Herbert, C.; Hubbell, J. Thin polymer layers formed by polyelectrolyte
multilayer techniques on biological surfaces. Langmuir, 1999, 15, 5355-5362.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

115

Eldor, A., Fuks, Z., Levine, R. F., and Vlodavsky, I., “Measurement o f platelet and
megakaryocyte interaction with the subendothelial extracellular matrix”, Methods in
Enzymology, 169, 76 (1989).
Ellis, S. G., O'Neill, W. W., Bates, E. R., Walton, J. A., Nabel, E. G., and Topol, E. J.,
Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours
after symptom onset: report o f an initial experience, Journal o f the American College o f
Cardiology, 13, 1122(1989).
Ellis, S. G., Roubin, G. S., King, S. B. d., Douglas, J. S. J., and Cox, W. R., Importance
o f stenosis morphology in the estimation o f restenosis risk after elective percutaneous
transluminal coronary angioplasty, American Journal o f Cardiology, 63, 30 (1989).
Erlemeier, H. H., Zangemeister, W., Burmester, L., Schofer, J., Mathey, D. G., and
Bleifeld, W., Bleeding after thrombolysis in acute myocardial infarction, European Heart
Journal, 10, 16 (1989).
Estavillo, D., Ritchie, A., Diacovo, T. G., and Cruz, M. A., Functional analysis o f a
recombinant glycoprotein Ia/IIa (Integrin alpha(2)beta(l)) I domain that inhibits platelet
adhesion to collagen and endothelial matrix under flow conditions, Journal of Biological
Chemistry, 274, 35921 (1999).
Fang, M., P. S. Grant, M. J. McShane, G. B. Sukhorukov, V. O. Golub and Y. M. Lvov,
“Magnetic Bio/Nanoreactor with Multilayer Shells o f Glucose Oxidase and Inorganic
Nanoparticles”, Langmuir, 2002a.
Fang, M., H. Ai, R. Cush, P. Russo, Y. M. Lvov, “Layer-by-Layer Electrostatic
Assembly o f Biocolloids: Encapsulation o f Tobacco Mosaic Vims and Fabrication o f
Glucose Oxidase Nano-Reactor”, ACS, 2002b.
Famdale, R. W., Winkler, A. B., Martin, B. R., and Bames, M. J., Inhibition o f human
platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that o f
adrenaline, but interactive with that o f thrombin, Biochemical Journal, 282 ( Pt 1), 25
(1992).
Faull, R. J., Du, X., Ginsberg, M. H., Ed. (1994). Receptors on Platelets. Methods In
Enzymology, Academic Press, Inc.
Febbraio, M. and R. L. Silverstein (1990). “Identification and characterization o f LAMP1 as an activation-dependent platelet surface glycoprotein.” Journal o f Biological
Chemistry 265(30): 18531-7.
Fijnheer, R., Modderman, P. W., Veldman, H., Ouwehand, W. H., Nieuwenhuis, H. K.,
Roos, D., and de Korte, D., Detection o f platelet activation with monoclonal antibodies
and flow cytometry. Changes during platelet storage, Transfusion, 30, 20 (1990).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

116

Fitzgerald, L. A., Steiner, B., Rail, S. C. J., Lo, S. S., and Phillips, D. R., Protein
sequence o f endothelial glycoprotein Ilia derived from a cDNA clone. Identity with
platelet glycoprotein Ilia and similarity to V'integrin , Journal o f Biological Chemistry,
262, 3936(1987).
Fitzpatrick, F. A., Gorman, R. R., Me Guire, J. C., Kelly, R. C., Wynalda, M. A., and
Sun, F. F., A radioimmunoassay for thromboxane B2, Analytical Biochemistry, 82, 1
(1977).
Forstermann, U., Pollock, J. S., Schmidt, H. H., Heller, M., and Murad, F., Calmodulindependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in
the particulate and cytosolic fractions o f bovine aortic endothelial cells., Proceedings o f
the National Academy o f Sciences o f the United States o f America, 88, 1788 (1991).
Fox, J. E., Aggerbeck, L. P., and Bemdt, M. C., Structure o f the glycoprotein Ib.IX
complex from platelet membranes, Journal o f Biological Chemistry, 263, 4882 (1988).
Freeman, G., Dyer, R. L., Juhos, L. T., St John, G. A., and Anbar, M., Identification of
nitric oxide (NO) in human blood., Archives o f Environmental Health, 33, 19.
Frelinger, A. L. d., Lam, S. C., Plow, E. F., Smith, M. A., Loftus, J. C., and Ginsberg, M.
H., Occupancy o f an adhesive glycoprotein receptor modulates expression of an antigenic
site involved in cell adhesion, Journal of Biological Chemistry, 263, 12397 (1988).
Frelinger, A. L. d., Cohen, I., Plow, E. F., Smith, M. A., Roberts, J., Lam, S. C., and
Ginsberg, M. H., Selective inhibition of integrin function by antibodies specific for
ligand-occupied receptor conformers, Journal o f Biological Chemistry, 265, 6346 (1990).
Fressinaud, E., Baruch, D., Girma, J. P., Sakariassen, K. S., Baumgartner, H. R., and
Meyer, D., von Willebrand factor-mediated platelet adhesion to collagen involves platelet
membrane glycoprotein Ilb-IIIa as well as glycoprotein lb, Journal o f Laboratory and
Clinical Medicine, 112, 58 (1988).
Fujikawa, L. S., Foster, C. S., Gipson, I. K., and Colvin, R. B., Basement membrane
components in healing rabbit comeal epithelial wounds: immunofluorescence and
ultrastructural studies, Journal of Cell Biology, 98, 128 (1984).
Fuster, V., Steele, P. M., and Chesebro, J. H., Role o f platelets and thrombosis in
coronary atherosclerotic disease and sudden death, Journal o f the American College of
Cardiology, 5, 175B (1985).
Fuster, V., Stein, B., Ambrose, J. A., Badimon, L., Badimon, J. J., and Chesebro, J. H.,
Atherosclerotic plaque rupture and thrombosis. Evolving concepts, Circulation, 82, 1147
(1990).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

117

Fuster, V., Badimon, J., Chesebro, J. H., and Fallon, J. T., Plaque rupture, thrombosis,
and therapeutic implications, Haemostasis, 26 Suppl 4, 269 (1996).
Fuster, V., Mechanisms o f arterial thrombosis: foundation for therapy, American Heart
Journal, 135, S361 (1998).
Garthwaite, J., Charles, S. L., and Chess_Williams, R., Endothelium-derived relaxing
factor release on activation of NMDA receptors suggests role as intercellular messenger
in the brain., Nature, 336, 385 (1988).
Gatter, K. C., Cordell, J. L., Turley, H., Heryet, A., Kieffer, N., Anstee, D. J., and Mason,
D. Y., The immunohistological detection o f platelets, megakaryocytes and thrombi in
routinely processed specimens [see comments], Histopathology, 13, 257 (1988).
Gautam, A., Densmore, C. L., Xu, B., and Waldrep, J. C., Enhanced gene expression in
mouse lung after PEI-DNA aerosol delivery., 2, 63 (2000).
George, J. N. (2000). “Platelets.” Lancet 355(9214): 1531-9.
Ginsberg, M. H., Forsyth, J., Lightsey, A., Chediak, J., and Plow, E. F., Reduced surface
expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets,
Journal o f Clinical Investigation, 71, 619 (1983).
Ginsberg, M. H., Frelinger, A. L., Lam, S. C., Forsyth, J., McMillan, R., Plow, E. F., and
Shattil, S. J., Analysis o f platelet aggregation disorders based on flow cytometric analysis
o f membrane glycoprotein Ilb-IIIa with conformation-specific monoclonal antibodies,
Blood, 76, 2017(1990).
Glynn, MF, “The role o f the platelet membrane in platelet function.
II. 5Hydroxytryptamine (serotonin) uptake,” Am J Clin Pathol, 60(5):636-643 (1973).
Goel, P. K., Shahi, M., Agarwal, A. K., Srivastava, S., and Seth, P. K., Platelet
aggregability and occurrence of restenosis following coronary angioplasty, International
Journal o f Cardiology, 60, 227 (1997).
Goto, S. and S. Handa (1998). “Coronary thrombosis. Effects o f blood flow on the
mechanism o f thrombus formation.” Japanese Heart Journal 39(5): 579-96.
Gralnick, H. R., Williams, S., McKeown, L., Connaghan, G., Shafer, B., Hansmann, K.,
Vail, M., and Fenton, J., Endogenous platelet fibrinogen surface expression on activated
platelets, Journal o f Laboratory and Clinical Medicine, 118, 604 (1991).
Gralnick, H. R., Williams, S. B., McKeown, L., Shafer, B., Connaghan, G. D., ansmann,
K., Vail, M., and Magruder, L., Endogenous platelet fibrinogen: its modulation after
surface expression is related to size-selective access to and conformational changes in the
bound fibrinogen, British Journal o f Haematology, 80, 347 (1992).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

118

Grines, C. L., Cox, D. A., Stone, G. W., Garcia, E., Mattos, L. A., Giambartolomei, A.,
Brodie, B. R., Madonna, O., Eijgelshoven, M., Lansky, A. J., 0_N eill, W. W., and
Morice, M. C., Coronary angioplasty with or without stent implantation for acute
myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.,
New England Journal o f Medicine, 341, 1949 (1999).
Guo, J., Murohara, T., Buerke, M., Direct measurement o f nitric oxide release from
vascular endotheliao cells, the American Physiological Society, 774 (1996).
Guyton, A. C., Hall, J. E. (1996). Muscle blood flow and cardiac output during exercises;
the coronary circulation and ischemic heart disease. Textbook o f Medical Physiology.
Philadelphia, W.B. Saunders Company: 253-264.
Guyton, A. C. and Hall, J. E. (1996). Hemostasis and Blood Coagulation. Textbook of
Medical Physiology. Philadelphia, W.B. Saunders Company: 463-473.
Hamberg, M., Svensson, J., and Samuelsson, B., Prostaglandin endoperoxides. A new
concept concerning the mode o f action and release o f prostaglandins, Proceedings o f the
National Academy o f Sciences o f the United States o f America, 71, 3824 (1974).
Hamburger, S. A. and R. P. McEver (1990). “GMP-140 mediates adhesion o f stimulated
platelets to neutrophils.” Blood 75(3): 550-4.
Hanson SR, Francesco I, Zaverio P, Ruggeri M, Marzec UM, Kunicki TJ, Montgomery
RR, Zimmerman TS and Harker LA, “Effects of monoclonal antibodies against the
platelet glycoprotein Ilb/IIIa complex on thrombosis and hemostasis in the baboon,” J
Clin Invest, 81, 149-158, 1988.
Hawiger, J. (1991). “Adhesive interactions of platelets and their blockade.” Annals o f the
New York Academy of Sciences 614: 270-8.
Hayward, C. P., Bainton, D. F., Smith, J. W., Horsewood, P., Stead, R. H., Podor, T. J.,
Warkentin, T. E., and Kelton, J. G., Multimerin is found in the alpha-granules o f resting
platelets and is synthesized by a megakaryocytic cell line, Journal of Clinical
Investigation, 91, 2630 (1993).
He, J-A.; Samuelson, L.; Li, L.; Kumar, J.; Tripathy, S. Oriented bacteriorhodopsin /
polycation multilayers by electrostatic layer-by-layer assembly. Langmuir, 1998, 14,
1674-1679.
Henrita_van_Zanten, G., Saelman, E. U., Schut_Hese, K. M., Wu, Y. P., Slootweg, P. J.,
Nieuwenhuis, H. K., de_Groot, P. G., and Sixma, J. J., Platelet adhesion to collagen type
IV under flow conditions., Blood, 88, 3862 (1996).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

119

Hodak, J.; Etchenique, R.; Calvo, E.; Singhal, K.; Bartlett, P. Layer-by-layer selfassembly o f glucose oxidase with a poly(allylamine) ferrocene redox mediator.
Langmuir, 1997, 13, 2708-2716.
Holmsen, H. (1990a). Biochemistry and function o f platelets: Composition of platelets.
Hematology Fourth edition. W. J. Williams, Beutler, E., Erslev, A. J., Lichtman, M. A.
New York, McGraw-Hill, Inc.: 1182-1200.
Holmsen, H. (1990b). Metabolism o f platelets. Hematology Fourth edition. W. J.
Williams, Beutler, E., Erslev, A. J., Lichtman, M. A. New York, McGraw-Hill, Inc.:
1200-1233.
Holmsen, H. a. D., C. A. (1992). Measurement of Secretion o f Lysosomal Acid
Glycosidases. Platelets: Receptors, Adhesion, Secretion Part A. J. Hawiger. San Diego,
Academic Press, Inc. 169: 336-351.
Hong, J.-D.; Lowack, K.; Schmitt, J.; Decher, G. Layer-by-layer deposited multilayer
assemblies o f polyelectrolytes and proteins: from ultrathin films to protein arrays. Progr.
Colloid Polym. Sci., 1993, 93, 98-102.
Honour, A. J., Carter, R. D., and Mann, J. I., The effects o f changes in diet on lipid levels
and platelet thrombus formation in living blood vessels, British Journal o f Experimental
Pathology, 59, 390 (1978).
Horak, E. R., Leek, R., Klenk, N., LeJeune, S., Smith, K., Stuart, N., Greenall, M.,
Stepniewska, K., and Harris, A. L., Angiogenesis, assessed by platelet/endothelial cell
adhesion molecule antibodies, as indicator of node metastases and survival in breast
cancer, Lancet, 340, 1120 (1992).
Hourdille, P., Heilmann, E., Combrie, R., Winckler, J., Clemetson, K. J., and Nurden, A.
T., Thrombin induces a rapid redistribution of glycoprotein Ib-IX complexes within the
membrane systems o f activated human platelets, Blood, 76, 1503 (1990).
Hoylaerts, M. F. (1997). “Platelet-vessel wall interactions in thrombosis and restenosis
role o f von Willebrand factor.” Verhandelingen - Koninklijke Academie Voor
Geneeskunde Van Belgie 59(3): 161-83.
Hsu-Lin, S., C. L. Berman., (1984). “A platelet membrane protein expressed during
platelet activation and secretion. Studies using a monoclonal antibody specific for
thrombin-activated platelets.” Journal o f Biological Chemistry 259(14): 9121-6.
Huang, P. Y., Heliums, J. David, “Aggregation and Disaggreation Kinetics o f Human
Blood Platelets: Part II. Shear-induced Platelet Aggregation.” Biophysical Journal 65:
344-353,(1993).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

120

Huang, T. C., Graham, D. A., Nelson, L. D., and Alevriadou, B. R., Fibrinolytic agents
inhibit platelet adhesion onto collagen type I-coated surfaces at high blood flow
conditions., Blood Coagulation and Fibrinolysis, 9, 213 (1998).
Ikeda, Y., Handa, M., Kawano, K., Kamata, T., Murata, M., Araki, Y., Anbo, H., Kawai,
Y., Watanabe, K., Itagaki, I., The role o f von Willebrand factor and fibrinogen in platelet
aggregation under varying shear stress, Journal of Clinical Investigation, 87, 1234 (1991).
Her, R. Multilayers o f colloidal particles. J. Colloid Interface Sci., 21, 569-594 (1966).
Jacobsen, M. D., Weil, M., and Raff, M. C., Role o f Ced-3/ICE-family proteases in
staurosporine-induced programmed cell death., Journal o f Cell Biology, 133, 10 4 1
(1996).
Jaffe, E. A., Hoyer, L. W., and Nachman, R. L., Synthesis o f von Willebrand factor by
cultured human endothelial cells, Proceedings o f the National Academy o f Sciences o f
the United States o f America, 71, 1906 (1974).
Jennings, L. K., Ashmun, R. A., Wang, W. C., and Dockter, M. E., Analysis o f human
platelet glycoproteins Ilb-IIIa and Glanzmann's thrombasthenia in whole blood by flow
cytometry, Blood, 68, 173 (1986).
Kaplan, D. R., Chao, F. C., Stiles, C. D., Antoniades, H. N., and Scher, C. D., Platelet
alpha granules contain a growth factor for fibroblasts, Blood, 53, 1043 (1979).
Kaplan, K. L., Broekman, M. J., Chemoff, A., Lesznik, G. R., and Drillings, M., Platelet
alpha-granule proteins: studies on release and subcellular localization, Blood, 53, 604
(1979).
Kastrati, A., Schomig, A., Seyfarth, M., Koch, W., Elezi, S., Bottiger, C., Mehilli, J.,
Schomig, K., and von Beckerath, N., PLA polymorphism of platelet glycoprotein Ilia and
risk o f restenosis after coronary stent placement, Circulation, 99, 1005 (1999).
Kastrati, A., Schomig, A., Seyfarth, M., Koch, W., Elezi, S., Bottiger, C., Mehilli, J.,
Schomig, K., and von Beckerath, N., PLA polymorphism of platelet glycoprotein Ilia and
risk of restenosis after coronary stent placement, Circulation, 99, 1005 (1999).
Kehrel, B. (1995). “Platelet-collagen interactions.” Seminars in Thrombosis and
Hemostasis 21(2): 123-9.
Klein, L. W. and J. Rosenblum (1990). “Restenosis after successful percutaneous
transluminal coronary angioplasty.” Progress in Cardiovascular Diseases 32(5): 365-82.
Kleinfeld, E.; Ferguson, G. Stepwise formation o f multilayered nanostructural films from
macromolecular precursors. Science, 1994, 265, 370-373.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

121

Kojima, H., Nakatsubo, N., Kikuchi, K., Kawahara, S., Kirino, Y., Nagoshi, H., Hirata,
Y., and Nagano, T., Detection and imaging o f nitric oxide with novel fluorescent
indicators: diaminofluoresceins., Analytical Chemistry, 70, 2446 (1998).
Kojima, H., Urano, Y., Kikuchi, K., Higuchi, T., Hirata, Y., Nagano, T., “Fluorescent
Indicators for Imaging Nitric Oxide Production”, Angewandte Chemie International
Edition, pp. 3209-3212, Vol. 38, Issue 21, 1999.
Kong, W.; Wang, L.; Gao, M.; Zhou, H.; Zhang, X.; Li, W.; Shen, J. Immobilized bilayer
glucose isomerase in porous trimethylamine polystyrene based on molecular deposition.
J. Chem. Soc., Chem. Commun., 1994, 1297-1298.
Kong, J.; Lu, Z.; Lvov, Y.; Desamero, R.; Frank, H.; Rusling, J. Direct electrochemistry
o f cofactor redox sites in bacterial photosynthetic reaction center protein. J. Am. Chem.
Soc., 1998, 120, 7371-7372.
Kong, J.; Sun, W.; Wu, X.; Deng, J.; Lvov, Y.; Desamero, R.; Frank, H.; Rusling, J. Fast
reversible electron transfer from photosynthetic reaction center from wild type
Rhodobacter spheroids re-constituted in polycation sandwiched monolayer film.
Bioelectrochem. Bioenerg., 1999,48, 101-107.
Konstantopoulos, K., Wu, K. K., Udden, M. M., Banez, E. I., Shattil, S. J., and Heliums,
J. D., Flow cytometric studies o f platelet responses to shear stress in whole blood,
Biorheology, 32, 73 (1995).
Korneev, D.; Lvov, Y.; Decher, G.; Schmitt, J. Neutron reflectivity analysis o f self
assembled film superlattices with alternate layers o f deuterated and hydrogenated
polystyrensulfonate and polyallyamine. Physica B, 1995, 2 1 3 /2 1 4 , 954-956.
Kotov, N.; Dekany, I.; Fendler, J. Layer-by-layer self-assembly o f polyelectrolytesemiconductor nanoparticle composite. J. Phys. Chem., 1995, 99, 13065-13069.
Lake_Bruse, K. D., Faraci, F. M., Shesely, E. G., Maeda, N., Sigmund, C. D., and
Heistad, D. D., Gene transfer o f endothelial nitric oxide synthase (eNOS) in eNOSdeficient mice., American Journal o f Physiology, 277, H770 (1999).
Lakowicz, J. R. (1999). Fluorophores. Principles o f Fluorescence Spectroscopy, Plenum
Pub Corp: 63-91.
Lam, SC-T, JBC 260:11107, 1985.
Lane, G. E. and D. R. J. Holmes (2000). “Primary angioplasty for acute myocardial
infarction in the elderly.” Coronary Artery Disease 11(4): 305-13.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

122

Lantoine, F., Trevin, S., Bedioui, F., Devynck, J. (1995). “Selective and sensitive
electrochemical measurement o f nitric oxide in aqueous solution: discussion and new
results.” Journal of Electroanalytical Chemistry 392: 85-89.
Lantoine, F., Brunet, A., Bedioui, F., Devynck, J., and Devynck, M. A., Direct
measurement of nitric oxide production in platelets: relationship with cytosolic Ca2+
concentration., Biochemical and Biophysical Research Communications, 215, 842
(1995).
Leasche, M.; Schmitt, J.; Decher, G.; Bouwman, W.; Kjaer, K. Detailed structure o f
molecularly thin polyelectrolyte multilayer films on solid substrates as revealed by
neutron reflectometry. Macromolecules, 1998, 31, 8893-8906.
Li M., H. Ai, D. K. Mills, Y. M. Lvov, B. K. Gale, “Increasing the Alignment o f Smooth
Muscle Cells by 100 pm Channels with Micro- and Nano- Technology”, IEEE, 2002
Meeting.
Lindahl, T. L., Festin, R., and Larsson, A., Studies o f fibrinogen binding to platelets by
flow cytometry: an improved method for studies o f platelet activation., Thrombosis and
Haemostasis, 68, 221 (1992).
Liska, J., Jonsson, A., Lockowandt, U., Herzfeld, I., Gelinder, S., and Franco-Cereceda,
A., Arterial patch angioplasty for reconstruction o f proximal coronary artery stenosis,
Annals o f Thoracic Surgery, 68, 2185 (1999).
Liska, J., A. Jonsson, (1999). “Arterial patch angioplasty for reconstruction of proximal
coronary artery stenosis.” Annals o f Thoracic Surgery 68(6): 2185-9; discussion 2190.
Little, W. C., Applegate, R. J. (1996). “Role o f Plaque Size And Degree o f Stenosis in
Acute Myocardial Infarction.” Cardiology Clinics 14(2): 221-228.
Looney, R. J., Abraham, G. N., and Anderson, C. L., Human monocytes and U937 cells
bear two distinct Fc receptors for IgG, Journal o f Immunology, 136, 1641 (1986).
Lowenstein, C. J., Dinerman, J. L., and Snyder, S. H., Nitric oxide: a physiologic
messenger., Annals of Internal Medicine, 120, 227 (1994).
Lvov, Y., Decher, G; Mohwald, H. Assembly, structural characterization and thermal
behavior o f layer-by-layer deposited ultrathin films of polyvinylsulfate and
polyallylamine. Langmuir, 1993d, 9, 481-486.
Lvov, Y., Decher, G., Sukhorukov, G. Assembly o f thin films by means o f successive
deposition o f alternate layers o f DNA and poly(allylamine). Macromolecules, 1993a, 26,
5396-5399.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

123

Lvov, Y., Haas, H.; Decher, G.; Mohwald, H.; Kalachev, A. Assembly o f polyelectrolyte
molecular films onto plasma treated glass. J. Phys. Chemistry, 1993b, 97, 12835-12841.
Lvov, Y.; Essler, F.; Decher, G. The combination o f polyanion/polycation self-assembly
and Langmuir-Blodgett transfer for the construction o f superlattice films. J. Phys.
Chemistry, 1993c, 97, 13773-13777.
Lvov, Y.; Ariga, K.; Kunitake, T. Layer-by-layer assembly o f alternate protein / polyion
ultrathin films. Chemistry Letters, 1994c, 2323-2326.
Lvov, Y.; Haas, H.; Decher, G.; Mohwald, H.; Mikhailov, A.; Mtchedlishvily, B.;
Morgunova, E.; Vainshtein, B. Successive deposition o f alternate layers of
polyelectrolytes and charged virus. Langmuir, 1994a, 10, 4232-4236.
Lvov, Y., Decher, G. Assembly o f multilayer ordered films by alternating adsorption of
oppositely charged macromolecules. Crystallography Reports, 1994b, 39, 696-716.
Lvov, Y.; Ariga, K.; Ichinose, I.; Kunitake, K. Assembly o f multicomponent protein
films by means o f electrostatic layer-by-layer adsorption. J. Am. Chem. Soc., 1995, 117,
6117-6123.
Lvov, Y.; Ariga, K.; Ichinose, I.; Kunitake, T. Molecular film assembly via layer-bylayer adsorption o f oppositely charged macromolecules (linear polymer, protein, and
clay) and o f concanavalin A / glycogen pair. Thin Solid Films, 1996, 284, 797-801.
Lvov, Y.; Ariga, K ; Ichinose, I.; Kunitake, T. Alternate assembly o f ordered multilayers
o f Si02 and other nanoparticles and polyions. Langmuir, 1997, 13, 6195-6203.
Lvov, Y.; Rusling, J.; Thomsen, D.; Papadimitrakopoulos, F.; Kawakami, T.; Kunitake,
T. High-speed multilayer assembly by alternate adsorption o f silica nanoparticles and
linear polycation. J. Chem. Soc., Chem. Commun., 1998a, 1229-1230.
Lvov, Y., Onda, M.; Ariga, K ; Kunitake, T. Ultrathin films o f charged polysaccharides
assembled alternately with linear polyions. J. Biomater. Sci., Polym. Ed., 1998b, 9, 345355.
Lvov, Y. Electrostatic layer-by-layer assembly o f proteins and polyions. In book: Protein
Architecture: Interfacial Molecular Assembly and Immobilization Biotechnology, Ed: Y.
Lvov and H. Mohwald, M. Dekker Publ., New York, 2000, 125-167.
Lvov, Y.; Caruso, F. Anal. Chem., 2001a, 73, 4212.
Lvov, Y., A. Antipov, A. Mamedov, H. Mohwald, and G. B. Sukhorukov, “Urease
Encapsulation in Nanoorganized Microshells” Nano Letters, 2001b, Vol. 1, No. 3

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

124

MacIntyre, I., Zaidi, M., Alam, A. S., Datta, H. K., Moonga, B. S., Lidbury, P. S.,
Hecker, M., and Vane, J. R., Osteoclastic inhibition: an action o f nitric oxide not
mediated by cyclic GMP., Proceedings o f the National Academy o f Sciences o f the
United States o f America, 88, 2936 (1991).
Malek, A. M., Alper, S. L., and Izumo, S., Hemodynamic shear stress and its role in
atherosclerosis, JAMA, 282, 2035 (1999).
Malinski, T. and Z. Taha (1992). “Nitric oxide release from a single cell measured in situ
by a porphyrinic-based microsensor [see comments].” Nature 358(6388): 676-8.
Malinski, T., Radomski, M. W., Taha, Z., and Moncada, S., Direct electrochemical
measurement o f nitric oxide released from human platelets, Biochemical and Biophysical
Research Communications, 194, 960 (1993).
Malinski, T., Radomski, M. W., Taha, Z., and Moncada, S., Direct electrochemical
measurement o f nitric oxide released from human platelets., Biochemical and
Biophysical Research Communications, 194, 960 (1993).
Mao, G.; Tsao, Y.; Tirrell, M.; Davis, H. T.; Hessel, V.; Ringsdorf, H. Self-assembly o f
photopolymerizable bolaform amphiphile mono and multilayers. Langmuir, 1993, 9,
3461-3470.
Marzocchi, A., Marrozzini, C., Piovaccari, G., Fattori, R., Castriota, F., D’Anniballe, G.,
Branzi, A., and Magnani, B., [Restenosis after coronary angioplasty: its pathogenesis and
prevention], Cardiologia, 36, 309 (1991).
Mazzucato, M., Spessotto, P., Masotti, A., De_Appollonia, L., Cozzi, M. R., Yoshioka,
A., Perris, R., Colombatti, A., and De_Marco, L., Identification o f domains responsible
for von Willebrand factor type VI collagen interaction mediating platelet adhesion under
high flow., Journal o f Biological Chemistry, 274, 3033 (1999).
McCann, D. S., Tokarsky, J., and Sorkin, R. P., Radioimmunoassay for plasma
thromboxane B2, Clinical Chemistry, 27, 1417 (1981).
McEver, R. P. and M. N. Martin (1984). “A monoclonal antibody to a membrane
glycoprotein binds only to activated platelets.” Journal o f Biological Chemistry 259(15):
9799-804.
McEver, R. P. (1990). “Properties o f GM P-140, an inducible granule membrane protein
o f platelets and endothelium.” Blood Cells 16(1): 73-80; discussion 80-3.
McGregor, J.; Clemetson, K.; James, E.; Luscher, E.; Dechavannne, M. Biochim.
Biophys. Acta., 1980, 599, 473.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

125

Mellion, B. T., Ignarro, L. J., Ohlstein, E. H., Pontecorvo, E. G., Hyman, A. L., and
Kadowitz, P. J., Evidence for the inhibitory role o f guanosine 3', 5'-monophosphate in
ADP-induced human platelet aggregation in the presence o f nitric oxide and related
vasodilators., Blood, 57, 946 (1981).
Mendelsohn, M. E., O'Neill, S., George, D., and Loscalzo, J., Inhibition o f fibrinogen
binding to human platelets by S-nitroso-N-acetylcysteine, Journal o f Biological
Chemistry, 265, 19028 (1990).
Michelson, A. D., Ellis, P. A., Barnard, M. R., Matic, G. B., Viles, A. F., and Kestin, A.
S., Downregulation o f the platelet surface glycoprotein Ib-IX complex in whole blood
stimulated by thrombin, adenosine diphosphate, or an in vivo wound [see comments],
Blood, 77, 770(1991).
Michelson, A. D., Benoit, S. E., Furman, M. I., Breckwoldt, W. L., Rohrer, M. J.,
Barnard, M. R., and Loscalzo, J., Effects o f nitric oxide/EDRF on platelet surface
glycoproteins, American Journal o f Physiology, 270, HI 640 (1996).
Michelson, A. D., Barnard, M. R., Krueger, L. A., Frelinger, A. L. r., and Furman, M. I.,
Evaluation of platelet function by flow cytometry, Methods, 21, 259 (2000).
Modderman, P. W., Admiraal, L. G., Sonnenberg, A., and von dem Bome, A. E.,
Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane,
Journal of Biological Chemistry, 267, 364 (1992).
Mohwald, H. Colloids Surf., 2000, 171, 25.
Moncada, S., Palmer, R. M., and Higgs, E. A., Biosynthesis o f nitric oxide from Larginine. A pathway for the regulation of cell function and communication., Biochemical
Pharmacology, 38, 1709 (1989).
Moritz, M. W., Reimers, R. C., Baker, R. K., Sutera, S. P., and Joist, J. H., Role of
cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress,
Journal of Laboratory and Clinical Medicine, 101, 537 (1983).
Moroi, M., Jung, S. M., Shinmyozu, K., Tomiyama, Y., Ordinas, A., and Diaz_Ricart,
M., Analysis o f platelet adhesion to a collagen-coated surface under flow conditions: the
involvement o f glycoprotein VI in the platelet adhesion., Blood, 88, 2081 (1996).
Moroi, M. and S. M. Jung (1997). “Platelet receptors for collagen.” Thrombosis and
Haemostasis 78(1): 439-44.
Murad, F. (1999). “Discovery o f some of the biological effects o f nitric oxide and its role
in cell signaling.” Bioscience Reports 19(3): 133-54.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

126

Murata, K., Izuka, PC., and Furuhashi, T., Effects o f chondroitin polysulphate on
thrombus-formation and serum lipid levels, Experientia, 25, 611 (1969).
Mustard, J. F., Packham, M. A., Kinlough-Rathbone, R. L. (1990). “Platelets, Blood
flow, and the vessel wall.” Circulation 81(suppl I): I-24-I27.
Nakamura, T., Kambayashi, J., Okuma, M., and Tandon, N. N., Activation of the GP IlbIlla complex induced by platelet adhesion to collagen is mediated by both alpha2betal
integrin and GP VI, Journal o f Biological Chemistry, 274, 11897 (1999).
Naqvi, T. Z., Shah, P. K., Ivey, P. A., Molloy, M. D., Thomas, A. M., Panicker, S.,
Ahmed, A., Cercek, B., and Kaul, S., Evidence that high-density lipoprotein cholesterol
is an independent predictor of acute platelet-dependent thrombus formation, American
Journal of Cardiology, 84, 1011 (1999).
Nieuwenhuis, H. K., van Oosterhout, J. J., Rozemuller, E., van Iwaarden, F., and Sixma,
J. J., Studies with a monoclonal antibody against activated platelets: evidence that a
secreted 53,000-molecular weight lysosome-like granule protein is exposed on the
surface o f activated platelets in the circulation, Blood, 70, 838 (1987).
NIH, 2000. http://rsb.info.nih.gov/nih-image/
Niimi, Y., Ichinose, F., Ishiguro, Y., Terui, K., Uezono, S., Morita, S., and Yamane, S.,
The effects o f heparin coating o f oxygenator fibers on platelet adhesion and protein
adsorption., Anesthesia and Analgesia, 89, 573 (1999).
O'Bnen, J. R. (1990). “Shear-induced platelet aggregation.” Lancet 335(8691): 711-3.
Onda, M.; Ariga, K.; Kunitake, T. Activity and stability o f glucose oxidase in molecular
films assembled alternately with polyions. J. Biosci. Bioeng., 1999, 87, 69-75.
Oura, Y. (1994). “[The effects of platelet-activating factor (PAF) on the collagen-induced
whole blood aggregation].” Rinsho Byori. Japanese Journal o f Clinical Pathology 42(1):
63-9.
Palmer, R. M., Ferrige, A. G., and Moncada, S., Nitric oxide release accounts for the
biological activity o f endothelium-derived relaxing factor., Nature, 327, 524 (1987).
Papadopoulos, N. G., Dedoussis, G. V., Spanakos, G., Gritzapis, A. D., Baxevanis, C. N.,
and Papamichail, M., An improved fluorescence assay for the determination o f
lymphocyte-mediated cytotoxicity using flow cytometry., Journal of Immunological
Methods, 177, 101 (1994).
Patton, S. R. (1997) Nitric Oxide in the Cardiovascular System. Ph. D Dissertation,
Oakland University. 53-53.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

127

Pigazzi, A., Heydrick, S., Folli, F., Benoit, S., Michelson, A., and Loscalzo, J., Nitric
oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase
activity in human platelets, Journal o f Biological Chemistry, 274, 14368 (1999).
Pitrowski, J. J., Hunter, G. C., Eskelson, C. D., Sethi, G. K., Copeland, J. C., McIntyre,
K. E., Cottrell, E. D., Aguirre, M. L., and Bernhard, V. M., Lipid peroxidation: a possible
factor in late graft failure o f coronary artery bypass grafts., Journal of Vascular Surgery,
13, 652(1991).
Plow, E. F., Srouji, A. H., Meyer, D., Marguerie, G., and Ginsberg, M. H., Evidence that
three adhesive proteins interact with a common recognition site on activated platelets,
Journal o f Biological Chemistry, 259, 5388 (1984).
Pommersheim, R.; Schrezenmeir, J.; Vogt, W. Immobilization o f enzymes by multilayer
microcapsules. Macromol. Chem. Phys., 1994, 195, 1557-1567.
Prentice, C. R. (1990). “Pathogenesis o f thrombosis.” Haemostasis 20 Suppl 1: 50-9.
Pytela, R., Pierschbacher, M. D., Ginsberg, M. H., Plow, E. F., and Ruoslahti, E., Platelet
membrane glycoprotein Ilb/IIIa: member o f a family o f Arg-Gly-Asp-specific adhesion
receptors, Science, 231, 1559 (1986).
Qiu, X., S. Leporatti, E. Donath, and H. Mohwald, “Studies on the Drug Release
Properties o f Polysaccharide Multilayers Encapsulated Ibuprofen Microparticles”,
Langmuir, 2001; 17(17); 5375-5380.
Radomski, M. W., Palmer, R. M., and Moncada, S., Endogenous nitric oxide inhibits
human platelet adhesion to vascular endothelium, Lancet, 2, 1057 (1987).
Rasmussen, C., Thiis, J. J., Clemmensen, P., Efsen, F., Arendrup, H. C., Saunamaki, K.,
Madsen, J. K., and Pettersson, G., Significance and management of early graft failure
after coronary artery bypass grafting: feasibility and results o f acute angiography and rere-vascularization., European Journal o f Cardio-Thoracic Surgery, 12, 847 (1997).
Rosenblum, W. I (1997). “Platelet adhesion and aggregation without endothelial
denudation or exposure o f basal lamina and/or collagen.” Journal of Vascular Research
34(6): 409-17.
Rosenfeld, S. I., Looney, R. J., Leddy, J. P., Phipps, D. C., Abraham, G. N., and
Anderson, C. L., Human platelet Fc receptor for immunoglobulin G. Identification as a
40,000-molecular-weight membrane protein shared by monocytes, Journal o f Clinical
Investigation, 76, 2317 (1985).
Ross, M. H., Romrell, L. J., Kaye, G. I. (1995a). Connective Tissue. Histology A Text
and Atlas. Baltimore, Williams & Wilkins: 94-115.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

128

Ross, J. M., Mclntire, L. V., Moake, J. L., and Rand, J. H., Platelet adhesion and
aggregation on human type VI collagen surfaces under physiological flow conditions,
Blood, 85, 1826(1995).
Ruggeri, Z. M., Bader, R., and de Marco, L., Glanzmann thrombasthenia: deficient
binding o f von Willebrand factor to thrombin-stimulated platelets, Proceedings o f the
National Academy o f Sciences o f the United States o f America, 79, 6038 (1982).
Ruggeri, Z. M. (1991). “The platelet glycoprotein Ib-IX complex.” Progress in
Hemostasis and Thrombosis 10: 35-68.
Saelman, E. U., Nieuwenhuis, H. K., Hese, K. M., de_Groot, P. G., Heijnen, H. F., Sage,
E. H., Williams, S., McKeown, L., Gralnick, H. R., and Sixma, J. J., Platelet adhesion to
collagen types I through VIII under conditions o f stasis and flow is mediated by GPIa/IIa
(alpha 2 beta 1-integrin)., Blood, 83, 1244 (1994).
Salvemini, D., de Nucci, G., Gryglewski, R. J., and Vane, J. R., Human neutrophils and
mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor,
Proceedings o f the National Academy o f Sciences o f the United States o f America, 86,
6328 (1989).
Samuelsson, B., Hamberg, M., Malmsten, C., and Svensson, J., The role o f prostaglandin
endoperoxides and thromboxanes in platelet aggregation, Advances in Prostaglandin and
Thromboxane Research, 2, 737 (1976).
Sander, H. J., Slot, J. W., Bouma, B. N., Bolhuis, P. A., Pepper, D. S., and Sixma, J. J.,
Immunocytochemical localization of fibrinogen, platelet factor 4, and beta
thromboglobulin in thin frozen sections o f human blood platelets, Journal o f Clinical
Investigation, 72, 1277 (1983).
Sato, J., Nair, K., Hiddinga, J., Eberhardt, N. L., Fitzpatrick, L. A., Katusic, Z. S., and
0_Brien, T., eNOS gene transfer to vascular smooth muscle cells inhibits cell
proliferation via upregulation o f p27 and p21 and not apoptosis., Cardiovascular
Research, 47, 697 (2000).
Sauerbrey, G. Z. Physik., 1959, 155, 206.
Schmitt, J.; Griinewald, T.; Krajer, K.; Pershan, P.; Decher, G.; Loshe, M. The internal
structure o f layer-by-layer adsorbed polyelectrolyte films: a neutron and X-ray
reflectivity study. Macromolecules, 1993, 26, 7058-7063.
Schmitt, J.; Decher, G.; Dressik, W.; Brandow, S.; Geer, R.; Shashidhar, R.; Calvert, J.
Metal nanoparticles / polymer superlattice films: Fabrication and control o f layer
structure. Adv. Materials, 1997, 9, 61-65.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

129

Schwartz, R. S., Murphy, J. G., Edwards, W. D., Camrud, A. R., Vliestra, R. E., and
Holmes, D. R., Restenosis after balloon angioplasty. A practical proliferative model in
porcine coronary arteries, Circulation, 82, 2190 (1990).
Sekimoto, H. (1980). “[Lipid metabolism and atherosclerosis—especially on ultrastructure
o f endothelial free surface in human arteries related to thrombus and atherosclerosis
(author's transl)].” Nippon Naika Gakkai Zasshi. Journal o f Japanese Society o f Internal
Medicine 69(10): 1250-5.
Senogles, SE, and Nelsestuen, GL, (1983). von Willebrand factor. A protein which binds
at the cell surface interface between platelets J. Biol. Chem. 258: 12327-12333.
Shattil, S. J., Hoxie, J. A., Cunningham, M., and Brass, L. F., Changes in the platelet
membrane glycoprotein Ilb.IIIa complex during platelet activation, Journal o f Biological
Chemistry, 260, 11107 (1985).
Shattil, S. J., Cunningham, M., and Hoxie, J. A., Detection o f activated platelets in whole
blood using activation-dependent monoclonal antibodies and flow cytometry, Blood, 70,
307(1987).
Shattil, S. J., Regulation o f platelet anchorage and signaling by integrin alpha lib beta 3,
Thrombosis and Haemostasis, 70, 224 (1993).
Shattil, S. J. and M. H. Ginsberg (1997). “Perspectives series: cell adhesion in vascular
biology. Integrin signaling in vascular biology.” Journal o f Clinical Investigation 100(1):
1-5.
Shattil, S. J., Kashiwagi, H., and Pampori, N., Integrin signaling: the platelet paradigm,
Blood, 91,2645(1998).
Shin, H., Katogi, T., Yozu, R., and Kawada, S., Surgical angioplasty o f left main
coronary stenosis complicating supravalvular aortic stenosis, Annals of Thoracic Surgery,
67, 1147(1999).
Sixma, J. J. and P. G. de Groot (1991). “von Willebrand factor and the blood vessel
wall.” Mayo Clinic Proceedings 66(6): 628-33.
Smith, J. B. (1987a). Formation o f prostaglandins and thromboxanes. Platelet Responses
and Metabolism. II. Receptors and Metabolism. H. Holmsen. Boca Raton, CRC Press:
287.
Smith, J. B. (1987b). “Pharmacology o f thromboxane synthetase inhibitors.” Federation
Proceedings 46(1): 139-43.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

130

Smith, C. C., Stanyer, L., Cooper, M. B., and Betteridge, D. J., Platelet aggregation may
not be a prerequisite for collagen-stimulated platelet generation o f nitric oxide, Biochim
Biophys Acta, 1473, 286 (1999).
Sneddon, J. M. and J. R. Vane (1988). “Endothelium-derived relaxing factor reduces
platelet adhesion to bovine endothelial cells.” Proceedings o f the National Academy of
Sciences o f the United States o f America 85(8): 2800-4.
Song, M., Li, J., and Yang, F. C., Studies o f human platelet ultrastructure and quantitative
analyses o f membrane glycoprotein nB/IIIA in shear stress-induced platelet quick release
reaction.,, 103, 166 (1990).
Steg, P. G., D. Himbert. (1999). “[Angioplasty in acute myocardial infarction].” Archives
Des Maladies Du Coeur Et Des Vaisseaux 92(11 Suppl): 1627-35.
Stenberg, P. E., Shuman, M. A., Levine, S. P., and Bainton, D. F., Redistribution of
alpha-granules and their contents in thrombin-stimulated platelets, Journal o f Cell
Biology, 98, 748 (1984).
Stenberg, P. E., McEver, R. P., Shuman, M. A., Jacques, Y. V., Bainton, D. F. (1985). “A
platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma
membrane after activation.” Journal o f Cell Biology 101: 880.
Stuehr, D. J., Cho, H. J., Kwon, N. S., Weise, M. F., and Nathan, C. F., Purification and
characterization o f the cytokine-induced macrophage nitric oxide synthase: an FAD- and
FMN-containing flavoprotein., Proceedings o f the National Academy o f Sciences o f the
United States o f America, 88, 7773 (1991).
Sukhorukov, G.; Mohwald, H.; Decher, G.; Lvov, Y. Layer-by-layer assembly o f DNA
and polynucleotides films by means o f alternate adsorption with polycations. Thin Solid
Films, 1996, 284, 220-223.
Sukhorukov, G.; Moroz, N.; Larionova, N.; Donath, E.; Mohwald, H. Encapsulation of
proteins by layer-by-layer adsorption o f polyelectrolytes. J. Microencapsulation, 2000,
17,418-522.
Turitto, V. T., Weiss, H. J., and Baumgartner, H. R., Decreased platelet adhesion on
vessel segments in von Willebrand's disease: a defect in initial platelet attachment,
Journal o f Laboratory and Clinical Medicine, 102, 551 (1983).
Turitto, V. T., Weiss, H. J., Zimmerman, T. S., and Sussman, I. I., Factor VUI/von
Willebrand factor in subendothelium mediates platelet adhesion, Blood, 65, 823 (1985).
Venturini, C. M. and J. E. Kaplan (1992). “Thrombin induces platelet adhesion to
endothelial cells.” Seminars in Thrombosis and Hemostasis 18(2): 275-83.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

131

Wagner, D. D. and V. J. Marder (1984). “Biosynthesis o f von Willebrand protein by
human endothelial cells: processing steps and their intracellular localization.” Journal of
Cell Biology 99(6): 2123-30.
Wagner, C. L., Mascelli, M. A., Neblock, D. S., Weisman, H. F., Coller, B. S., and
Jordan, R. E., Analysis o f GPIIb-IIIa receptor number by quantification o f 7E3 binding to
human platelets, Blood, 88, 907 (1996).
Warkentin, T. E., Powling, M. J., and Hardisty, R. M., Measurement o f fibrinogen
binding to platelets in whole blood by flow cytometry: a micromethod for the detection o f
platelet activation, British Journal o f Haematology, 76, 387 (1990).
Weigensberg, B. I., More, R. H., and Sumiyoshi, A., Lipid profile in the evolution of
experimental atherosclerotic plaques from thrombus, Laboratory Investigation, 33, 43
(1975).
Weiss, H. J., Turitto, V. T., and Baumgartner, H. R., Platelet adhesion and thrombus
formation on subendothelium in platelets deficient in glycoproteins Ilb-IIIa, lb, and
storage granules, Blood, 67, 322 (1986).
White, J. G. (1968). “The dense bodies o f human platelets. Origin o f serotonin storage
particles from platelet granules.” American Journal o f Pathology 53(5): 791-808.
Wu, Y. P., van Breugel, H. H., Lankhof, H., Wise, R. J., Handin, R. I., de Groot, P. G.,
and Sixma, J. J., Platelet adhesion to multimeric and dimeric von Willebrand factor and
to collagen type III preincubated with von Willebrand factor, Arteriosclerosis,
Thrombosis, and Vascular Biology, 16, 611 (1996).
Yang, Z., Ruschitzka, F., Rabelink, T. J., Noll, G., Julmy, F., Joch, H., Gafner, V.,
Aleksic, I., Althaus, U., and Luscher, T. F., Different effects o f thrombin receptor
activation on endothelium and smooth muscle cells o f human coronary bypass vessels.
Implications for venous bypass graft failure., Circulation, 95, 1870 (1997).
Yano, Y., Kambayashi, J., Kawasaki, T., and Sakon, M., Quantitative determination of
circulating platelet microparticles by flow cytometry, International Journal o f Cardiology,
47, S13 (1994).
Yoo, D.; Lee, J.; Rubner, M. Investigations o f new self-assembled multilayer thin films
based on alternately adsorbed layers o f polyelectrolytes and functional dye molecules.
Mat. Res. Symp. Proc., 1996, 413, 395-400.
Yoo, D.; Shiratori, S.; Rubner, M. Controlling bilayer composition and surface
wettability o f sequentially adsorbed multilayers of weak polyelectrolytes.
Macromolecules, 1998, 31, 4309-4318.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

132

Zeiher, A. M. (1996). “Endothelial vasodilator dysfunction: pathogenetic link to
myocardial ischaemia or epiphenomenon?” Lancet 348 Suppl 1: s i 0-2.
Zucker-Franklin, D. (1990). Platelet morphology and function. Hematology. W. J.
Williams, Beutler, E., Erslev, A. J. and Lichtman, M. A. New York, McGraw-Hill, Inc.:
1172-118.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

